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vABSTRACT
Gene circuits are complex biological networks composed of numerous regula-
tory elements, including transcription factors, mRNAs, and microRNAs. Flu-
orescent in situ hybridization (FISH) is a powerful method for spatially map-
ping expression levels of RNA elements within an intact organism, but tradi-
tional methods exhibit at least one of the following drawbacks: low signal-
to-background, arduous and/or destructive multiplexing, and non-quantitative
signal. These issues are all overcome using in situ amplification based on the
mechanism of hybridization chain reaction (HCR). With this approach, nu-
cleic acid probes complementary to RNA targets trigger the self-assembly of
fluorophore-labeled nucleic acid hairpins into tethered fluorescent amplification
polymers. In situ HCR enables straightforward multiplexing, high signal-to-
background, and quantitative signal. Here, we address three key scenarios in
which HCR enables novel applications for in situ hybridization. First, we address
the challenge of sorting cell subpopulations based on mRNA abundance using
flow cytometry to enable high-throughput measurement of the signal inten-
sity from individual cells. High signal is required to overcome the background
autofluorescence integrated over the volume of each cell. Quantitative HCR
signal amplification enables multi-dimensional sorting of mammalian cell lines
based on expression levels of multiple target mRNAs. Second, we address the
challenge of mapping multiple microRNA and mRNA targets simultaneously.
Traditional methods enable mapping of single microRNA targets in isolation and
use costly LNA probes with proprietary compositions that differ for each target.
Here we develop in situ HCR for multiplexed mapping not only of microRNAs,
but of microRNAs and mRNAs together, using non-proprietary 2’OMe-RNA
probes for miRNA targets and DNA probes for mRNA targets. Third, to en-
able studies of gut flora, we address the challenge of mapping spatial relation-
ships between different bacterial species within the intact mouse colon. In situ
HCR enables multiplexed discrimination of multiple closely-related Bacteroides
species with rRNAs that differ by only a few nucleotides. In summary, this
thesis presents in situ HCR as a tool for multiplexed analysis of diverse RNA
classes and expands the range of gene circuit regulatory elements that can be
spatially and quantitatively mapped.
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1C h a p t e r 1
INTRODUCTION
Throughout human history, progress in our collective understanding of the pure
sciences has led to the rise of complementary engineering disciplines. These
disciplines set out to distill our knowledge of natural systems into a concise
set of design principles for rationally designing artificial ones. Consequently,
biological engineering aims to apply engineering principles to biological systems.
Perhaps the most elusive, yet impactful goal of biological engineering is to
enable rational design of biological gene circuits and gene circuit components
[1–4].
It is important to recognize two complementary fields of study: systems and
synthetic biology. Together they are locked in a mutualistic cycle; systems bi-
ologists approach existing biological systems with a top-down approach [5–7],
and they often discover design principles that synthetic biologists can adopt
in their bottom-up approach to building gene circuits de novo [8]. Long her-
alded as a new frontier in biological engineering, synthetic biology promises to
revolutionize mankind’s long-standing, systemic problems, ranging from waste
management [9], clean fuel production [10], cancer treatment [11], and many
more [4, 12, 13].
Future implications aside, it is becoming clearer that gene circuits, unlike elec-
tronic circuits, are not quite predictable [14]. To name just two differences,
gene circuits are composed of a far wider set of elements than their electronic
counterparts, and stochastic fluctuations in expression are a crucial feature,
rather than an unwanted side effect [15–17]. The sheer number and diver-
sity of regulatory elements in gene circuits, such as messenger RNA (mRNA),
microRNA (miRNA), ribosomal RNA (rRNA), and many more, add layers to
their complexity. As a result, the systems biology approach is crucial to build
our design principles by studying naturally-occurring circuits. In order to enable
biologists to learn these design principles, a new generation of tools is required
to allow for detailed study of naturally-occurring gene circuits.
Simultaneous to efforts in synthetic and systems biology, the field of molecular
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Figure 1.1: Multiplexed in situ amplification via hybridization chain re-
action (HCR). a. HCR mechanism. Metastable fluorescent hairpins self-
assemble into fluorescent amplification polymers upon detection of a cognate
initiator. Initiator I1 nucleates with hairpin H1 via base-pairing to single-
stranded toehold "a," mediating a branch migration that opens the hairpin
to form complex I1H1 containing single-stranded segment "c*-b." This com-
plex nucleates with hairpin H2 via base-pairing to toehold "c," mediating a
branch migration that opens the hairpin to form complex I1H1H2 containing
single-stranded segment "b*-a*." Thus, the initiator sequence is regenerated,
providing the bases for a chain reaction of alternating H1 and H2 addition
steps. Stars denote fluorophores. b. Detection stage. Probe sets are hy-
bridized to RNA targets and then unused probes are washed from the sample.
c. Amplification stage. Initiators trigger self-assembly of tethered HCR poly-
mers and then unused hairpins are washed from the sample. d. Experimental
timeline. The same two-stage protocol is used regardless of number of tar-
gets. For multiplexed experiments (two-color example depicted), probe sets
for different target RNAs carry orthogonal initiators that trigger orthogonal
HCR amplification cascades labeled by spectrally distinct fluorophores.
3programming has created design principles and tools for building programmable
nucleic acid mechanisms with tangible functionality [18–21]. Hybridization
chain reaction (HCR, Figure 1.1) [18] is a crucial nucleic acid mechanism that
has enabled diverse applications. Specifically, HCR is a mechanism by which
two kinetically trapped nucleic acid hairpin molecules (H1 and H2 in 1.1a) coex-
ist metastably, but in the presence of a cognate initiator (I1), react to assemble
a long, double-stranded amplification polymer. Figure 1.1 is a schematic rep-
resentation of HCR (1.1a) and the generalized in situ HCR protocol (1.1b-d).
This technology has been harnessed to allow for parallel in situ amplification of
up to five target mRNA molecules within whole-mount zebrafish embryos[22,
23], an advancement that will revolutionize the use cases for in situ hybridiza-
tion in years to come [24, 25].
In situ HCR represents a fundamental addition to the current toolkit for study-
ing gene circuits. Yet gene circuits are composed of many different components
in many different settings and organisms. Thus, it is critical to extend in situ
HCR to allow for the sampling of a variety of gene circuit elements beyond
mRNAs, as well as new settings to enable profoundly new applications. Here,
we extend in situ HCR to cover new applications and a new class of short RNA
targets.
In Chapter II, it is demonstrated that in situ HCR can be applied to profiling
heterogeneous mammalian cell populations and subpopulations can be isolated
based upon expression of an mRNA transcript.
In Chapter III, modified short probes are engineered to enable simultaneous
detection of microRNA and longer RNA targets within an intact zebrafish em-
bryo.
In Chapter IV, short probes are coupled with optimized experimental conditions
and HCR amplification to enable species-specific identification and spatial lo-
calization within mouse colon tissue sections.
Appendices A, B, and C provide supplementary information for Chapters II, III,
and IV, respectively.
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6C h a p t e r 2
MULTIPLEXED QUANTITATIVE CELL SORTING BASED ON
RNA ABUNDANCE
2.1 Introduction
Flow cytometry is a crucial data acquisition tool used in research and clinical
settings for many applications, including cell counting, sorting, and biomarker
detection [1–5]. Cytometry allows for simultaneous multi-parametric analysis
of the physical properties of thousands of cells per second. Fluorescence-
activated cell sorting (FACS) is a specialized form of flow cytometry; using
FACS, it is possible to sort a heterogeneous mixture of cells on a cell-by-cell
basis, based upon any logical combination of the measured parameters. FACS
is used frequently in biological research labs because it provides a fast and high-
throughput measurement of fluorescent signals from individual cells, as well as
physical separation of cells of interest [6–8].
Coupling flow cytometry with fluorescent in situ hybridization (flow-FISH) is a
technique that is growing in popularity [9–16]. The specificity of probe base-
pairing of FISH combined with the many advantages of flow cytometry make
this an enticing tool for a variety of applications, including telomere length de-
termination [9, 10], cellular identification and gene expression [11], monitoring
viral multiplication in infected cells [12], and bacterial community analysis and
enumeration [13].
In order for staining to be useful in cytometry and cell sorting, sufficient am-
plification of the fluorescent signal is required to separate heterogeneous pop-
ulations. When measuring fluorescent signal with cytometry, an entire cell
represents the smallest physical unit that can be measured, or voxel. Since
most cells do not contain many copies of any single transcript, measured in-
tensities from cytometry include a large component of integrated background.
This represents a significant challenge for current methods of flow-FISH, which
suffer from drawbacks, such as poor separation of heterogeneous mixtures due
to low signal-to-background [13, 17]. Additionally, given that mRNAs represent
just one type of element in natural gene circuits, stronger signal amplification
7is necessary in order to detect smaller or sequence constrained targets, such as
microRNAs or mRNA transcript variants.
Hybridization chain reaction (HCR) is a technology developed by the Pierce Lab
in 2004 [18], and it has been demonstrated as a superior amplification method
for the in situ detection of mRNA in whole-mount zebrafish embryos [19]. Here
we propose a protocol for adapting this in situ amplification technique for use
with cell suspension. In doing so, we preserve the advantages conferred by
HCR, including high signal-to-background, multiplexed target detection, rela-
tively quantitative measurements, and the potential for short target detection.
Additionally, the work presented here utilizes RNA HCR; the planned switch to
DNA HCR will offer greater signal-to-background when dealing with low-copy
or short RNA targets.
HCR amplification for in situ hybridization occurs in two stages independent of
the number of target mRNAs (Figure 2.1). In the detection stage, all target
mRNAs are detected simultaneously via in situ hybridization of complementary
RNA probes; unused probes are washed from the sample. Each target mRNA
is addressed by a probe set containing one or more RNA probe species; dif-
ferent targets are addressed by probe sets carrying orthogonal initiators. Each
RNA probe carries four identical initiators, thus each supports formation of
four RNA HCR polymers. In the amplification stage, fluorescent signals are
generated for all target mRNAs simultaneously using RNA HCR. Orthogonal
initiators trigger formation of orthogonal HCR polymers, labeled with spectrally
distinct fluorophores; unused hairpins are washed from the sample prior to flow
cytometry.
To characterize the performance of HCR as a method for isolating cells based
on mRNA expression, we designed a battery of experiments to rigorously test
in situ HCR’s signal-to-background, target specificity, and ability to quantify
target expression. Samples are analyzed using flow cytometry and cell sorting.
Additional data for all figures can be found in Appendix A.
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Figure 2.1: Multiplexed in situ amplification via hybridization chain reac-
tion (HCR). a. Detection stage. Probe sets are hybridized to mRNA targets
and then unused probes are washed from the sample. b. Amplification stage.
Initiators trigger self-assembly of tethered HCR polymers and then unused hair-
pins are washed from the sample. c. Experimental timeline. The same two-
stage protocol is used regardless of number of target mRNAs. For multiplexed
experiments (single color example depicted), probe sets for different target
mRNAs carry orthogonal initiators that trigger orthogonal HCR amplification
cascades labeled by spectrally distinct fluorophores (denoted by red stars).
92.2 Probe Set Optimization
Signal observed from samples that have undergone in situ HCR can be compo-
nentized into four categories: autofluorescence (AF), non-specific amplification
of hairpins without a present probe containing a cognate initiator (NSA), non-
specific binding of the probe to an off-target (NSD), or true signal (SIG). This
section highlights how HCR probe sets against transgenic targets are optimized
and proposes a method for optimizing those against endogenous targets. Note
that probe set optimization is not always necessary, but is a useful tool when
required.
2.2.1 Transgenic Targets
In order to characterize the performance of a given HCR probe set, signal-to-
background can be calculated from samples that feature each of the aforemen-
tioned categories. All samples are subject to experimental conditions of in situ
HCR, but lack key components. Table 2.1 depicts these control samples. A
crucial aspect of this type of analysis is that each form of background can only
be measured in its native summation. For example, it is impossible to study
NSA in isolation, but rather the sum of AF and NSA can be measured directly.
Cell Line Sample Type HCR Probe HCR Amplifier
Either AF 7 7
Either AF + NSA 7 3
Wild-Type AF + NSA + NSD 3 3
Transgenic AF + NSA + NSD + SIG 3 3
Table 2.1: Description of how negative and positive control samples can be
created for in situ HCR.
Figure 2.2 demonstrates proof-of-concept for this type of validation for a probe
set designed against d2egfp. Transgenic and wild-type cell lines were used for
determining "AF + NSA + NSD + SIG" and "AF + NSA + NSD," respec-
tively. Typical performance of good (2.2a) and bad (2.2b) probes are shown.
Additionally, 2.2c,d showcase performance of unoptimized and optimized probe
sets. Qualitatively, background and signal histograms become entirely separa-
ble using an optimized probe set. 2.2e,f demonstrate the data shown in 2.2c,d,
respectively, with linear scaling.
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Figure 2.2: Sample probe optimization results. Cell lines are HEK293T
(black) and HEK293 + d2egfp (red). Probe sets target d2egfp transcript.
Each histogram is composed of 50,000 cell counts. a. Typical performance
of a single good probe. b. Typical performance of a single poor probe. c.
Performance of entire probe set including poor probes. Linear plot shown in
(e). d. Resultant performance of optimized probe set excluding poor probes.
Linear plot shown in (f). e. Linear-scaled axis for data shown in (c). f. Linear-
scaled axis for data shown in (d). Samples: HEK293T, HEK293 + d2egfp.
Target: transgenic mRNA Tg(d2egfp).
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2.2.2 Endogenous Targets
Optimizing probe sets against endogenous targets presents an entirely different
challenge. Although a scramble probe, designed to have no sequence specificity
to any transcript present, is often used, this method does not measure sequence
specific NSD. Here, we present a novel method for probe optimization using
pairwise combinations of probes.
To perform pairwise probe optimization, probes within a probe set are applied
combinatorially containing initiators for orthogonal HCR amplification systems
to expose poor performing probes. Two caveats are that this method requires
a single probe to produce sufficient signal to overcome AF + NSA + NSD, and
the probe set being tested must contain at least two good probes. If these
conditions are met, then it follows that pairs of good probes will produce high
correlation, while probe pairs containing one or more bad probes will not pro-
duce high correlation. For a probe set containing n probes, n·(n−1)
2
experiments
are required to complete the optimization.
Table 2.2 outlines the results of experiments performed to optimize a probe
set consisting of five probes targeting beta-actin (actb). Probes listed in rows
of the table were amplified with Alexa488-labeled HCR, and probes listed in
columns were amplified with Alexa647-labeled HCR. Entries in the table refer
to Pearson correlation coefficients calculated on a cell-by-cell basis between
the two fluorescent channels.
Probe # 1 2 3 4 5
1 7 0.03 0.02 0.02 0.02
2 7 7 0.77 0.73 0.75
3 7 7 7 0.50 0.75
4 7 7 7 7 0.73
5 7 7 7 7 7
Table 2.2: Overview of experiments required to complete pairwise opti-
mization of actb probe set. Entries refer to Pearson correlation coefficient
calculated on a cell-by-cell basis between signal collected in orthogonal HCR
amplified channels. High correlation indicates both probes in a pair bind cor-
rect target sufficiently to overcome background (AF + NSA + NSD). Low
correlation implies one or both probes in the pair is poorly performing.
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Figure 2.3: Sample probe optimization results for targeting endogenous
transcript actb. a. Density histogram depicting correlation between two chan-
nels when unoptimized probe set is split into two orthogonally-amplified sets. b.
Density histogram depicting correlation between two channels when optimized
probe set is split into two orthogonally-amplified sets. Sample: HEK293T.
Target: endogenous mRNA actb. Each panel depicts 50,000 cell counts.
From Table 2.2, it is clear that probe 1 performs poorly when paired with
any of the other four probes. Figure 2.3 demonstrates redundant detection
of actb using both unoptimized 2.3a and optimized 2.3b probe sets. Removal
of the bad probe improves the Pearson correlation coefficient from 0.04 to
0.91. This successful optimization is a strong proof-of-concept demonstration
of pairwise probe optimization, and could potentially be used for probe sets
against transgenic targets in cases in which obtaining a wild-type sample is
prohibitive.
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2.3 Comparison of Single vs. Quad Initiator HCR Probes
Validation of probes with four HCR initiators has been completed for cell sus-
pension experiments. By potentially increasing the signal by a factor of four by
switching to HCR probes with four initiators instead of one, NSD should also
increase by a factor of at least four. Autofluorescence and nonspecific HCR
amplification should remain constant, since they occur independent of the ini-
tiator. For regimes in which AF dominates relative to NSD, adding initiators
or probes is beneficial to signal-to-background.
Figure 2.4 shows this comparison between HCR probes with one and four ini-
tiators. This experiment involved using the HEK293T line as wild-type and the
HEK293 + d2egfp as a transgenic line and data acquisition with flow cytom-
etry. For both types of HCR probes, the same cell lines, target mRNA, probe
recognition sequence, and HCR amplifiers were used. The only variable was
the number of HCR initiators attached to the probe recognition sequence.
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Figure 2.4: Quantitative analysis of one versus four initiators per HCR
probe. a. Component depiction of signal and all sources of background. Back-
ground signals are very small relative to true signal. b. Signal-to-background
ratio calculation for each probe type. The probe set with four initiators yields
a signal-to-background ratio 2.7 fold over the single initiator probes. Sample:
HEK293T, HEK293 + d2egfp. Target: transgenic mRNA Tg(d2egfp). Each
panel represents 50,000 cell counts. Error bars are drawn as standard error
over three samples. n = 3.
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2.4 Troubleshooting in situ HCR with Heterogeneous Cell Populations
A significant engineering challenge was posed when optimizing the in situ HCR
protocol for detection of cells within heterogeneous cell mixtures. Cells in mix-
tures corresponding to the background peak showed higher fluorescence than
those from the same cell line in isolation (NSD). Crucially, the average signal
did not appear to change between homogeneous and heterogeneous samples.
Figure 2.5a demonstrates this increased NSD.
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Figure 2.5: Troubleshooting HCR with heterogeneous cell populations. a.
In situ HCR with heterogeneous cell mixtures using unoptimized conditions
for cell concentrations. b. Examining the effect of cell concentration upon
NSD peak. c. In situ HCR with heterogeneous cell mixtures using optimized
conditions for cell concentrations. Sample: mixtures of HEK293T, HEK293 +
d2egfp. Target: transgenic mRNA Tg(d2egfp). Each panel represents 50,000
cell counts.
It was determined that the root cause of the increased NSD in heterogeneous
cell mixtures was cell concentration of the in situ reaction. 2.5b shows a
zoomed version of the NSD peak within a heterogeneous mixture. The trend
indicates that as concentration of cells in the sample tube increases, so does the
fluorescence of the NSD peak. Furthermore, the issue can be traced directly
to the concentration of transgenic cells. Note that in 2.5a as the fraction of
transgenic cells increases, the size of the NSD shift also increases.
To mitigate this effect, we optimized hybridization volumes and cell counts
per reaction. 2.5c demonstrates the identical experiment in 2.5a but with the
optimized protocol. Note the shift has virtually disappeared. The data are
consistent with the hypothesis that if transgenic cells produce large numbers
of the transgene’s transcript, combined with imperfect retention of transcripts
after 4 % FA fixation, it is possible that transcripts are in a state of flux
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entering and leaving cells on an individual basis. Thus, as the concentration
of cells increases, it becomes more likely that the transgene will be detected in
wild-type cells. Further evidence to support this is given by Figure ??, in which
it is proven that the probe set used is highly specific. It is likely that probes are
detecting the correct target present in the incorrect cell type.
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2.5 Single Color Validation of in situ HCR
Figure 2.6 demonstrates the ability of HCR to discriminate two homogeneous
populations based on expression of a target transgenic mRNA. Additionally,
Figure 2.7 demonstrates the same data on a linear axis. HCR generated signal
in target cells that was fully separable from the background in cells that lacked
the target. This was demonstrated in the cases of two independent target
transgenic mRNAs: d2egfp (2.6a) and dsRed2 (2.6b). The results confirm
strong HCR amplification with high target specificity.
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Figure 2.6: Validation of fluorescent HCR in situ amplification with flow
cytometry. Fluorescence intensity histograms for background (wild-type cells)
and signal plus background (transgenic cells). Protein fluorescence is quenched
by heat and chemical treatment during the HCR protocol. Excellent discrim-
ination is indicated by the minimal overlap between background (gray) and
background plus signal (colored) histograms. Samples: HEK293T, HEK293 +
d2egfp, HEK293 + dsRed2. Targets: transgenic mRNAs: (a) Tg(d2egfp) and
(b) Tg(dsRed2). Probe sets: single HCR probe per target. Due to impuri-
ties in the vector integration process, a small population of wild-type cells are
observed in the Tg(dsRed2) cell line. Each histogram is composed of 50,000
cells. n = 3 (See Figure A.1).
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Figure 2.7: Validation of fluorescent HCR in situ amplification with flow
cytometry (linear axis). Data shown is identical to Figures 2.6 and A.1 but
with linear scaling along the fluorescence intensity axis. Samples: HEK293T,
HEK293 + d2egfp, HEK293 + dsRed2. Targets: transgenic mRNAs: (a)
Tg(d2egfp) and (b) Tg(dsRed2). Probe sets: single HCR probe per target.
Due to impurities in the vector integration process, a small population of wild-
type cells are observed in the Tg(dsRed2) cell line. Each histogram is composed
of 50,000 cells. n = 3 (See Figure A.2).
2.6 Single Color Validation of in situ HCR with Heterogeneous Mixtures
Figure 2.8 demonstrates in situ HCR’s consistent ability to maintain high dis-
crimination between cell types in mixtures of cell lines. Additionally, Figure 2.9
demonstrates the same data on a linear axis. Artificial mixtures of cell types
were created in varying ratios prior to HCR. Regardless of the composition of
the mixture, HCR allows clear separation of cell types on histograms. Further,
Figure 2.10 demonstrates identification and quantitation of the subpopulations
of cells within the heterogeneous mixtures.
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Figure 2.8: Detection of transgenic cells in artificial mixtures of varying
composition. Fluorescence intensity histograms for varying ratios of wild-type
and transgenic cell mixtures. Excellent discrimination indicates that HCR pro-
duces high signal-to-background regardless of composition of cell mixture. Cell
lines: HEK293T, HEK293 + d2egfp, HEK293 + dsRed2. Targets: transgenic
mRNAs: (a) Tg(d2egfp) and (b) Tg(dsRed2). Probe sets: single HCR probe
per target. Due to impurities in the vector integration process, a small pop-
ulation of wild-type cells are observable in the 100% Tg(dsRed2) sample and
contribute to all mixtures of wild-type and Tg(dsRed2) cells. Each histogram
is composed of 50,000 cells. n = 3 (See Figure A.3).
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Figure 2.9: Detection of transgenic cells in artificial mixtures of varying
composition (linear axis). Data shown is identical to Figures 2.8 and A.3 but
with linear scaling along the fluorescence intensity axis. Cell lines: HEK293T,
HEK293 + d2egfp, HEK293 + dsRed2. Targets: transgenic mRNAs: (a)
Tg(d2egfp) and (b) Tg(dsRed2). Probe sets: single HCR probe per target.
Due to impurities in the vector integration process, a small population of wild-
type cells are observable in the 100% Tg(dsRed2) sample and contribute to all
mixtures of wild-type and Tg(dsRed2) cells. Each histogram is composed of
50,000 cells.
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Figure 2.10: Quantitation of artificial mixtures of varying composition.
Using data from Figures 2.8 and A.3, cell subpopulations are quantified and
plotted on scatter plots. Each point refers to a single heterogeneous mix-
ture. Data falls on a line because every sample includes 50,000 cells. Cell
lines: HEK293T, HEK293 + d2egfp, HEK293 + dsRed2. Targets: transgenic
mRNAs: (a) Tg(d2egfp) and (b) Tg(dsRed2). Probe sets: single HCR probe
per target. Due to impurities in the vector integration process, a small pop-
ulation of wild-type cells are observable in the 100% Tg(dsRed2) sample and
contribute to all mixtures of wild-type and Tg(dsRed2) cells.
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2.7 Relative Quantitation of mRNA Abundance by Redundant Detection
Figures 2.11 (linear axes) and 2.12 (logarithmic axes) demonstrate the rel-
ative quantitation of mRNA abundance HCR provides. Additionally the 1-
dimensional histograms are overlaid to show consistency to Figures 2.6 and
2.7. To show this, redundant detection of a single mRNA target was per-
formed using two probe sets, each targeting unique regions of the mRNA, and
each triggering one of two orthogonal HCR amplifiers labeled with spectrally
distinct fluorophores. Redundant detection should therefore result in correlated
signal intensities if signal generated by HCR scales with target abundance. The
highly-correlated relationship between the two measurements for each target
(Pearson correlation coefficient r = 0.98 and r = 0.91 for Tg(d2egfp) and
Tg(dsRed2), respectively) indicates that HCR signal scales approximately lin-
early with the number of target mRNAs per cell. Additionally, the strong
correlation also implies the variability in the average HCR polymer length per
voxel (cell) is small relative to the variability of target mRNA abundance within
a population of cells. Thus, HCR signal generated for an mRNA target can be
used to quantify its relative abundance within a population of cells.
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Figure 2.11: Relative quantitation of mRNA abundance with flow cytom-
etry (linear axes). Two-color redundant detection of target mRNAs using
orthogonal probe sets that initiate spectrally distinct HCR amplifiers. Quan-
titative ability is inferred from high Pearson correlation coeffcients. Samples:
HEK293 + d2egfp, HEK293 + dsRed2. Targets: transgenic mRNAs: (a)
Tg(d2egfp) and (b) Tg(dsRed2). Probe sets: (a) three HCR probes for chan-
nel 1, single HCR probe for channel 2 and (b) two HCR probes for channel 1,
three HCR probes for channel 2. Due to impurities in the vector integration
process, a small population of wild-type cells are observable in the Tg(dsRed2)
cell line (cluster near origin in (b)). n = 3 (See Figure A.5).
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Figure 2.12: Relative quantitation of mRNA abundance with flow cytom-
etry (logarithmic axes). Two-color redundant detection of target mRNAs
using orthogonal probe sets that initiate spectrally distinct HCR amplifiers.
Quantitative ability is inferred from high Pearson correlation coeffcients. Sam-
ples: HEK293 + d2egfp, HEK293 + dsRed2. Targets: transgenic mRNAs:
(a) Tg(d2egfp) and (b) Tg(dsRed2). Probe sets: (a) three HCR probes for
channel 1, single HCR probe for channel 2 and (b) two HCR probes for channel
1, three HCR probes for channel 2. Due to impurities in the vector integration
process, a small population of wild-type cells are observable in the Tg(dsRed2)
cell line (cluster near origin in (b)). n = 3 (See Figure A.6).
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2.8 Multiplexed Cell Sorting Based on the Abundance of mRNA Targets
Figure 2.13 is a demonstration of multiplexed HCR being used to discriminate
and sort three cell populations within one mixture. Cell lines were examined
individually (Figure 2.13a) and then compared to the scatter plot obtained
when all three lines were mixed prior to HCR (Figure 2.13b). After sorting,
populations were analyzed once more to confirm homogeneous populations
were isolated (Figure 2.13c). The high degree of separation verifies HCR
amplification is sufficiently strong enough to provide multi-dimensional sorting
of cell populations based on mRNA abundance.
Figure 2.13: Multiplexed cell sorting based on mRNA abundance. a. Si-
multaneous detection of Tg(d2egfp) and Tg(dsRed2) in three pure cell lines:
HEK293 + dsRed2 (red), HEK293 + d2egfp (green), and HEK293T (cyan).
b. Characterization of cell type within an artificial mixture of cell lines from
(a) based on the presence or absence of mRNA targets. c. Fluorescence-
activated cell sorting (FACS) performed on the cell mixture from (b). Sorted
cell populations were analyzed to demonstrate the ability of HCR to be used
for the isolation of heterogeneous populations. Cell lines: HEK293T, HEK293
+ d2egfp, HEK293 + dsRed2. Targets: transgenic mRNAs Tg(d2egfp) and
Tg(dsRed2). Probe sets: three HCR probes per target. Due to impurities in
the HEK293 + dsRed2 line, a small number of cells are indistinguishable from
the wild-type.
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2.9 Conclusion
Coupling HCR amplification with flow cytometry enables a powerful new tool
for studying, quantifying, and profiling heterogeneous cell populations based
on mRNA abundance. HCR amplification confers high signal-to-background,
multiplexed target detection, relative quantitation of mRNA abundance, and
the potential for short target detection to the high-throughput analysis and
isolation tool that FACS provides. Existing techniques exhibit limitations in at
least one of these four areas, thus creating a need for this new tool.
In situ HCR can be used to quantify relative mRNA abundance between cells in a
sample. We demonstrate that HCR signal scales linearly, with high correlation,
as a function of target abundance. The variability of the average HCR polymer
length per voxel (cell) is small relative to the variability of mRNA abundance
within a population of cells with the targets we studied (Figure ??). The
combination of relative quantitation and high-throughput sampling offered by
FACS is an exciting development for in situ hybridization techniques.
We have presented validated properties of HCR amplification that allow for
multiplexed profiling of mRNA abundance. These properties can be used for
isolation of cells that exhibit combinations of mRNA abundance or scarcity
across multiple targets or biomarkers. With multiplexed target detection of
mRNA targets exhibiting bimodal expression (high versus low), in situ HCR
enables FACS of 2n distinct cell types, where n is the number of mRNA targets
(here we present n = 2 used to sort 3 distinct cell types). We show that in
a sample with three cell types (two of which each expressing a unique mRNA
transcript), all three populations can be successfully identified with high fidelity
using in situ HCR and FACS. Additionally, we propose that these properties
can be extended to any sufficiently highly-expressed mRNA target, including
endogenous transcripts, for performing logic-based cell population sorting based
on mRNA abundance.
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2.10 Future Directions
Future directions of this technology should capitalize upon HCR’s unique strengths.
One such key feature is the probe agnostic nature of HCR amplification. This
allows for switching probe designs without impacting amplification in situ. For
example, this can allow for HCR-amplified detection of short regulatory ele-
ments, such as microRNAs (detailed in Chapter 3) or other noncoding RNA
molecules.
Two immediate goals are to extend in situ HCR to include endogenous mRNA
and microRNA targets (inspired by efforts in Chapter 3). Second is to build
on the core application presented here: isolation of cell subpopulations. For
example, HCR detection of mRNA marker transcripts could be used to identify
and isolate subpopulations based on cell states in heterogeneous mixtures. The
ability to use HCR for transcriptome-level profiling of cell subpopulations based
on endogenous target would represent a powerful tool for cell biologists.
An emerging technology is mass cytometry, a technology that enables high-
throughput mass spectrometry-based analysis and sorting of cells [20–22]. Re-
cent developments have shown multiplexing of up to 40 different mRNA and
protein targets [22]. Given the modularity of HCR amplification, it is possible
to label HCR amplifiers with mass cytometry-compliant isotopes (mass cytom-
etry’s complement to fluorophores). This combination could enable hyper-
multiplexed detection of short regulatory elements in addition to mRNA and
proteins, enabling the mapping of entire gene circuits.
Another exciting application of the technology presented here is profiling of
bacteria found in environmental or clinical samples. Current methods for con-
ducting flow-FISH with bacterial samples are limited by techniques that do
not provide quantitative signal amplification [11, 13, 23–25] or cannot support
multiplexed target detection [13, 23]. HCR amplification can potentially solve
these issues by bringing programmable logic to signal generation. Further, in
situ HCR’s ability to quantify mRNA abundance permits sub-profiling of a cell
population exhibiting a broad range of expression for a given mRNA.
Additionally, this technique could be combined with RNA-Seq for profiling and
quantifying mRNA abundance in great detail [26, 27]. Current methods for
RNA-Seq depend on bulk measurements of many cells [27–30]. More recently,
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single cell RNA-Seq has emerged as a useful tool for developing mRNA tran-
scriptomes for single cells [31–34] . However, this technique can be prohibitively
expensive [33] and require relatively long times for completion [32], and data
obtained can be extremely difficult to interpret due to large variation from
cell-to-cell and low total cell count [35].
HCR amplification and FACS can provide relevant, high-throughput measure-
ments by isolating cell populations and analyzing their individual transcriptomes
with traditional RNA-Seq. This method significantly lowers the barrier-to-entry
to obtaining highly detailed RNA expression information offered by single cell
RNA-Seq.
Combining HCR amplification with high-throughput imaging, such as flow or
mass cytometry, is an application rich with potential. In Chapter 2, we pre-
sented a platform for building these techniques. Looking forward, it is crucial to
continue building on the strengths of HCR amplification by optimizing for short
or low-expression targets, as well as coupling to the latest advances elsewhere
to create compelling solutions for biologists.
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C h a p t e r 3
MULTIPLEXED MAPPING OF MICRORNA AND MRNA
EXPRESSION IN VERTEBRATE EMBRYOS
3.1 Introduction
Ever since their initial discovery more than 20 years ago in Caenorhabditis
elegans, microRNAs (miRNAs) have risen in importance within gene regulation
circuits [1–8], and much effort has been dedicated to unearthing details of
miRNA biogenesis and their role in post-transcriptional gene regulation in both
plants and animals. As our collective knowledge regarding the role of miRNAs
in gene regulation has grown, recent studies have applied this understanding
towards creating novel principles. These innovations range from predicting
miRNA target sites [9, 10], identifying miRNAs key to disease pathways [6, 8,
11, 12], and designing novel miRNA genes [13].
For decades biologists have relied upon in situ hybridization to obtain spatial
and cell type-specific information regarding mRNA expression. Current tech-
niques for detecting miRNA targets offer robust detection of a single target in
a range of sample types [14–23]. While these methods for improving miRNA
retention within samples [19, 24] and LNA-based oligonucleotide probes [14]
have allowed for the detection of miRNA targets using traditional in situ hy-
bridization protocols, several crucial hurdles remain. These include multiplexed
miRNA detection, co-detection of miRNAs with mRNAs, and easier probe syn-
thesis and use. Solving these problems would enable biologists to study miRNA
expression in relation to both expression of other microRNAs and key mRNAs
and significantly reduce the cost per experiment.
In order to create a fundamentally new platform for studying how miRNAs and
mRNAs are related within intact samples, two critical technical challenges must
be addressed. First, current probes targeting miRNAs tend to incorporate LNA
bases, which are proprietary, expensive, and difficult to design de novo. Second,
current signal amplification techniques are either incompatible with short target
detection [25], too weak to be useful within intact vertebrate embryos [26], or
cannot be used for multiplexing [14–23]. Here, we couple 2’-O-methylated
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...
mRNA probe set
miRNA probe
... ...mRNA target
miRNA target
Hybridize probes
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HCR initiators
HCR ampliers Amplify hairpins
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Growing HCR
polymers
miRNAmRNA
miRNAmRNA
b Detection stage
c Experimental timeline
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Add all probes/probe sets
Wash unbound probes
Add all ampliers
Wash unamplied hairpins
Image sample
Figure 3.1: Multiplexed in situ amplification via hybridization chain reac-
tion (HCR). a. Detection stage. Probe sets are hybridized to miRNA/mRNA
targets and then unused probes are washed from the sample. b. Amplifica-
tion stage. Initiators trigger self-assembly of tethered HCR polymers and then
unused hairpins are washed from the sample. c. Experimental timeline. The
same two-stage protocol is used regardless of number of target miRNA/mRNA
targets. For multiplexed experiments (two-color example depicted), probe sets
for different target RNAs carry orthogonal initiators that trigger orthogonal
HCR amplification cascades labeled by spectrally distinct fluorophores.
RNA probes with signal amplification via hybridization chain reaction (HCR)
[27–29] in order to reduce the per experiment cost by up to 10 times and
enable true target multiplexing in whole-mount zebrafish embryos. As a proof-
of-concept, we demonstrate four-color multiplexed in situ HCR involving the
co-detection of miRNA and mRNA targets.
HCR-based amplification for in situ hybridization has been engineered and
demonstrated to enable parallel multiplexing of up to five target mRNAs within
whole-mount zebrafish embryos [28, 29]. An HCR amplifier is composed of
two kinetically trapped fluorescent nucleic acid hairpin species (H1 and H2 in
Figure 1.1a) that, in the absence of a cognate initiator strand (I1), coexist
metastably. Presence of the initiator triggers a chain reaction in which H1 and
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H2 hairpins sequentially nucleate and open to assemble a long nicked double-
stranded fluorescent amplification polymer. Due to the large sequence space
available to the HCR amplifiers, orthogonal amplifiers have been designed for
the simultaneous amplification of multiple targets. As a result, the bottleneck
to the number of concurrent targets that can be detected is the number of
spectrally distinct fluorophores available, rather than the number of orthogonal
HCR amplifiers [28, 29].
In situ HCR offers four distinct advantages over traditional in situ hybridization
techniques. First, HCR is programmable, allowing for straightforward multi-
plexing of target detection and signal amplification within the same sample.
The same two-stage protocol was used independent of the number of target
mRNAs or miRNAs (Figure 3.1). Second, while HCR polymerization is based
upon a catalytic reaction, it reaches equilibrium within a reasonable timeframe
– this means amplification time does not need to be tuned on a per-target
basis to maximize signal-to-background. Third, HCR amplification polymers
are designed to remain attached to their initiators, preventing their diffusion
throughout the sample and ensuring sharp signal localization. Fourth, HCR
self-assembly occurs only in the presence of the initiator, thereby allowing for
hairpins to penetrate the sample before forming long polymers. These proper-
ties have been demonstrated in an in situ setting [28, 29].
These properties make HCR amplification an ideal fit for detection of miRNAs
in situ. In order to allow for simultaneous detection of miRNA and mRNA
targets, we defined two engineering challenges: straightforward probe design
and synthesis and protocol compatibility with in situ HCR detection of mRNAs.
Although HCR amplification is modular by design and is compatible with any
probe type, we found 2’-O-methylated RNA probes offered a few key advan-
tages over the more commonly used locked nucleic acid-based (LNA) probes.
While LNA probes have been successfully used to detect miRNA targets in situ
[14, 16–24, 30–35], we found key drawbacks to their use: design and synthesis
are relatively costly and strands are available only from a single vendor (Exiqon,
Inc.).
Short probes, like ones targeting miRNAs, have tended to incorporate LNA
bases due to the large increase in melting temperature their incorporation offers
(3-8 ◦C per base) [36]. Because of this large increase, short probes cannot
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be composed entirely of LNA bases and remain compatible with optimal in
situ hybridization conditions. Therefore, it is necessary to use some fraction
of LNA bases along with RNA or DNA bases, thus necessitating design and
testing. 2’-O-methylated RNA bases also grant increased melting temperature
per substituted base, albeit smaller gains (1-3 ◦C per base)[37]. We found this
to work in our favor – instead of being tasked with discovering the best ratio
of modified base to traditional base, we synthesize miRNA probes solely using
2’-O-methylated RNA. Compared to their LNA counterparts, these probes are
cheaper (∼10x) on a per-experiment basis (see Chapter 3.2 for calculation),
and the nucleotides are not proprietary. Crucially, we show the use of these
probes to detect miRNA targets simultaneously with standard DNA in situ HCR
probes to detect mRNA targets.
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3.3 Linear Unmixing for Decreased Autofluorescence
Spectral imaging and linear unmixing were employed in order to mitigate the
effect of autofluorescence in the samples using the ZEISS Zen Black software
with the Linear Unmixing module. This combination of pre- and post-processing
was used to characterize a fluorescent molecule’s emission fingerprint, rather
than attempting to distinguish them based solely upon bandpass filtering. Ref-
erence spectra for sample autofluorescence and Alexa Fluor dyes were collected
using identical imaging conditions to the in situ HCR data. For the multi-
channel samples, spectra were collected for each laser source: 488 nm, 514
nm, 561 nm, and 633 nm. All spectra were measured using 9.7 nm intervals
(Figure B.3). Further information can be found in Chapter 3.3.1 and Appendix
B.4.
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3.3.1 Comparison of Spectral Imaging and Linear Unmixing to Standard
Imaging
b
c
200 μm
Raw image Unmixed imagea
0 2048
Fluorescence intensity
Pi
xe
l c
ou
nt
s
Background from raw image
Background from unmixed image
Figure 3.2: Impact of linear unmixing on autofluorescence. a. Images
comparing a single channel when imaged normally and spectrally. Boxes
indicate sample autofluorescence plotted in histogram. b. Maximum in-
tensity z-projection of standard confocal microscopy images of multiplexed
mRNA/miRNA detection. c. Maximum intensity z=projection of spectral con-
focal microscopy and linear unmixed images of multiplexed mRNA/miRNA de-
tection. Note the subtraction of blood vessel-specific autofluorescence present
in (b) and absent in (c) (indicated by white arrows). Sample: Casper zebrafish
fixed at 72 hpf. Probes: one single-initiator DNA probe per target. Amplifiers:
four orthogonal HCR amplifiers carrying spectrally distinct fluorophores.
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Laser (nm) Standard Imaging (AU) Spectral Imaging (AU) Background Reduction (%)
488 600 200 67
514 2000 400 80
561 500 5 99
Table 3.2: Reduction of autofluorescence by spectral imaging and linear
unmixing. Values presented are mean intensities of boxes placed to extract
blood vessel-specific autofluorescence.
3.4 Multiplexed Detection of microRNA and mRNA Targets
In order to best demonstrate in situ HCR as a technique for the co-detection of
miRNA and mRNA targets within whole-mount zebrafish embryos, we designed
a proof-of-concept experiment detecting targets that are spatially distinct. Ref-
erence data from ZFIN is shown in Appendix B. Figure 3.3 shows simultaneous
mapping of three target miRNAs and one target mRNA with high signal-to-
background. Each miRNA target is detected using a single 2’-O-methlyated
RNA probe carrying a single HCR initiator, and the mRNA target is detected
using a probe set containing seven two-initiator DNA probes. The same two-
stage protocol is used, regardless of probe and target type using orthogonal
HCR amplifiers carrying spectrally distinct fluorophores. See Chapter 3.5 for
histogram and signal-to-background analysis for all targets.
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a
b
c
miR-96 miR-206 miR-9 hbae3
200 μm
50 μm
Figure 3.3: Multiplexed mapping of microRNA and mRNA targets in fixed
whole-mount zebrafish embryos. a. Expression atlas for three microRNAs
(miR-9, miR-206, miR-96) and one mRNA (hbae3). b. miRNA/mRNA ex-
pression of targets imaged via confocal microscopy at four planes within an
embryo. c. Full lateral view of expression of targets. Maximum intensity
projection composite image of the four channels. Sample: Casper zebrafish
embryos fixed at 72 hpf. Probe set: single 1-initiator 2’O-Me probe for mi-
croRNA and seven 2-initiator DNA probes for mRNA. Scale bars indicated on
images. All images were acquired spectrally and processed via linear unmix-
ing to subtract channel cross-talk and autofluorescence. See Appendix B for
details.
3.5 Histogram Analysis of microRNA and mRNA Mapping
Figure 3.4 shows histogram-based analysis of signal-to-background for each
target. Boxes were extracted from each replicate for each target to represent
the sum of signal + background and background. Box size was different across
targets, but consistent across replicates in order to account for the varying
spatial expression for each. Histograms demonstrate near complete separation
of signal + background and background intensities for all targets and replicates.
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Figure 3.4: Histogram analysis of signal-to-background. Columns 1-3 are
technical replicates of in situ HCR. Column 4 shows histograms extracted
from boxes overlaid on images columns 1-3. Rows correspond to different
target miRNA/mRNA. Solid boxes represent regions of signal + background,
and dotted boxes represent regions of background. All images were acquired
spectrally and processed via linear unmixing to subtract channel cross-talk and
autofluorescence.
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Target Signal Background Signal-to-Background
miR-96 2,000 ± 100 100 ± 50 20 ± 7
miR-206 900 ± 200 90 ± 80 10 ± 9
miR-9 2,000 ± 100 20 ± 7 100 ± 40
hbae3 2,000 ± 500 20 ± 20 90 ± 90
Table 3.3: Signal-to-background calculation for individual targets. Cal-
culations made using data extracted from boxes depicted in Figure 3.4. See
Appendix B for calculation details.
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3.6 Conclusion
Coupling in situ HCR amplification technology with straightforward, low cost
probe design and synthesis results in key improvements to dramatically increase
the functionality and robustness of in situ hybridization to detect miRNA tar-
gets. The 2’-O-methylated RNA probes used here are free of any design re-
quirements since they are composed of only 2’-O-methylated RNA nucleotides
and are significantly cheaper than LNA-based alternatives. Additionally, we en-
able simultaneous detection of multiple miRNA targets, as well as co-detection
of both miRNA and mRNA targets. To decrease sample autofluorescence and
increase the number of dyes available for use, we also employed spectral imag-
ing and linear unmixing. We believe this protocol enables fundamentally new
studies regarding the role of miRNAs within gene circuits in complex samples.
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3.7 Future Directions
This technology enables significant applications. Keys to enabling microRNA
detection in situ were advances in probe design as well as harnessing HCR
amplification.
Within the scope of this thesis, it may be possible to analyze and isolate cell
subpopulations based upon microRNA expression (see Chapter 2). Additionally,
while we focus here on microRNA targets, the technology proposed could be
adapted for detection of other kinds of short targets, including mRNA splice
variants.
Additionally, the spectral imaging methods used in this chapter can be extended
to expand our multiplexing ability, rather than being primarily used for back-
ground correction. Moving forward, it may be possible to increase the number
of simultaneous targets from four[38, 39]. Further in situ HCR is currently
being developed for detection of protein via antibody binding[40, 41].
In situ HCR can be a powerful tool for mapping diverse RNA target classes
while retaining spatial information. Here, we present the ability to detect both
long and short targets, specifically mRNA and microRNA targets. Looking
forward, we hope to expand the range of gene circuit components that can be
mapped, including proteins and other types of non-RNA targets.
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C h a p t e r 4
MULTIPLEXED MAPPING OF BACTERIAL SPECIES IN
MOUSE COLON TISSUE SECTIONS WITH HIGH
SPECIFICITY AND SELECTIVITY
4.1 Introduction
The biodiversity among microbes in the gastrointestinal (GI) system of humans
and other mammals is a unique function of a complex series of interactions and
events over the course of an individual’s lifetime. Although detailed understand-
ing of this process to the point when predictions become possible eludes us,
current research efforts have established several key drivers of gut biogeogra-
phy, including diet and nutrition [1–5], the effects of antimicrobials [6–9], the
presence of mucus [10, 11], and interactions with the native immune system
[12–14]. Additionally, dysbiosis, or imbalance in the abundance or composition,
of these microbes is increasingly being linked to various immune, metabolic, and
neurological disorders, such as inflammatory bowel diseases [15–17].
Key to understanding how microbial biogeography may impact human or host
health is developing a catalog of tools to survey the abundance and composition
of the GI tract and of microhabitats within, such as the crypts embedded
within the wall of the colon. These tools generally require choosing between
maintaining sample integrity or studying a comprehensive scope of microbes.
While attaining either goal in isolation can result in novel discovery, a tool that
advances both goals simultaneously would prove invaluable.
Next-generation sequencing is a valuable tool for polling a sample for all present
microbes, and it can portray the diversity, specificity, stability, and develop-
mental dynamics of gut microbiota. Despite recent advances to localize this
dissection [18, 19], these techniques ultimately cannot retain exact spatial in-
formation.
Current methods for performing in situ hybridization to identify bacteria within
mouse colon samples are consistently able to preserve sample integrity and
localize cells to microhabitats therein [20–24]. Indeed, probes against unique
regions of ribosomal RNA have been shown to be species-specific in bacteria
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extracted from caecal samples [25, 26]. Yet the current state-of-the-art has
not enabled effective multiplexing of multiple species-specific probes [20], and
autofluorescence can be a significant issue to contend with (Figure 4.3).
Hybridization chain reaction (HCR) has been demonstrated as a superior ampli-
fication method for in situ hybridization [27, 28]. Relative to current methods
for surveying gut biogeography, HCR offers key advantages: the ability to mul-
tiplex target detection and signal amplification, a modular design that allows for
the substitution of optimized probes, and high signal-to-background to enable
signal to overcome significant autofluorescence present in samples extracted
from the GI tract.
Here, we demonstrate in situ HCR as a tool that improves upon the virtues
of traditional in situ hybridization with increased signal-to-background and ex-
pands the technique’s ability to multiplex, allowing for simultaneous, species-
specific detection of multiple Bacteroides ribosomal RNA targets.
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a Detection stage
rRNA probe
... ...rRNA target
Hybridize probes
and wash
HCR ampliers Amplify hairpins
and wash
...
Growing HCR
polymers
b Amplication stage
c Experimental timeline
Add all probes/probe sets
Wash unbound probes
Add all ampliers
Wash unamplied hairpins
Image sample
......
......
HCR initiator
Figure 4.1: Multiplexed in situ amplification via hybridization chain reac-
tion (HCR). (a) Detection stage. Probe sets are hybridized to rRNA targets
and then unused probes are washed from the sample. (b) Amplification stage.
Initiators trigger self-assembly of tethered HCR polymers and then unused hair-
pins are washed from the sample. (c) Experimental timeline. The same two-
stage protocol is used regardless of number of target miRNA/mRNA targets.
For multiplexed experiments (single color example depicted), probe sets for
different target rRNAs carry orthogonal initiators that trigger orthogonal HCR
amplification cascades labeled by spectrally distinct fluorophores.
4.2 Validation of Literature Probe Sequences in Cell Culture
In order to validate probe sequences sourced from prior work [25, 26], we
sought to replicate results with cell culture samples. Figure 4.2 demonstrates
the results of four such species-specific probes with Bacteroides fragilis grown
in cell culture. Probes used were specific to B. fragilis, B. ovatus, B. theta, B.
vulgatus, and the universal 16S ribosomal RNA sequence EUB338.
Table 4.2 shows signal-to-background analysis for these images. Images were
thresholded based upon DAPI, and the resultant mask was applied to the
EUB338 (green) and species-specific probe (red) channels to calculate inten-
sities. Slide background was calculated by inverting the DAPI mask and ap-
plying it to the other channels. Mean and standard deviation are calculated
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B. fragilis probe
DAPI
Universal
Probe
Species
Specic
Probe
B. ovatus probe B. theta probe B. vulgatus probe
5 μm
B. fragilis cell culture
Figure 4.2: Discrimination ability of literature species-specific probes in
cell culture. Sample: Cell cultures of B. fragilis, B. vulgatus. Probes: one
fluorescent-labeled DNA probe per target.
over three replicates. Normalized signal is the species-specific signal across
species-specific probes normalized the signal observed from adding a probe
targeting B. fragilis to B. fragilis cell culture. Data confirms that sequences
demonstrate high specificity across four probes and Bacteroides species (other
species’ data not shown). Additionally, direct-labeled probes provide sufficient
signal-to-background with cell culture.
Target Species EUB338 Signal Species-Specific Signal Normalized Signal
Bacteroides fragilis 3,000 ± 3,000 10,000 ± 5,000 1
Bacteroides ovatus 4,000 ± 3,000 300 ± 400 0.03
Bacteroides theta 4,000 ± 5,000 800 ± 2,000 0.08
Bacteroides vulgatus 6,000 ± 4,000 600 ± 300 0.06
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4.3 Direct-labeled vs HCR Probes in Mouse Colon Tissue Sections
Building on the previous result, to demonstrate the necessity of HCR amplifica-
tion, we show that while current techniques are sufficient for discriminating bac-
terial species in cell culture (see 4.2), they fail to generate signal-to-background
sufficient enough to overcome autofluorescence of the mouse in tissue section
samples. Figure 4.3 shows tissue sections obtained from singly-germinated
mice (with B. fragilis) that were hybridized with probes direct-labeled with
Alexa Fluor 488 compared to the same probe amplified with an Alexa Fluor
488 labeled HCR system. Although bacterial cells are identifiable in both im-
ages, the high signal-to-background conferred by HCR amplification completely
overcomes sample autofluorescence (left panel) and enables significantly easier
detection of bacterial cells.
Direct-labeled probe HCR probe
10 μm
Figure 4.3: Motivation for HCR amplification for detecting bacteria in
mouse colon tissue sections. White arrow indicates autofluorescent regions
of the mouse colon, and red arrows indicate bacterial cells stained by probes
in situ. Note the high signal-to-background of HCR amplification overcomes
sample autofluorescence. Sample: Mouse colon tissue sections singly-colonized
with B. fragilis. Probe: one fluorescent-labeled DNA probe targeting a universal
16S region direct-labeled with Alexa Fluor 488 (left) or amplified with HCR
(right).
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4.4 Specificity of in situ HCR Probes in Mouse Colon Tissue Sections
Prior art established that short probes (17-20 nt) are able to discriminate Bac-
teroides species controlled samples [25, 26] and our work reinforced this (Figure
4.2). Due to the modularity inherent in HCR amplification, the optimal solution
is to couple state-of-the-art probes with state-of-the-art signal amplification.
With this model, hybridization conditions for the probe could be borrowed from
prior art, and amplification conditions for HCR could be recycled.
However, significant optimization for probe hybridization was necessary to
achieve high signal-to-background (see Appendix C for key optimization steps).
A protocol is presented here for multiplexed species-specific detection of Bac-
teroides species in fresh frozen mouse colon tissue sections (Appendix C.3).
Figure 4.4 demonstrates this species-specificity in regards to probes specific to
four Bacteroides species present in mouse colon sections colonized with each
of two Bacteroides species. Figure 4.4a involves mouse colon tissue sections
extracted from a mouse singly-colonized with B. fragilis, and stained with in
situ HCR with each of the four species-specific probes targeting unique 16S
rRNA regions of B. fragilis, B. ovatus, B. theta, and B. vulgatus (from left to
right). The top row of images shows HCR signal obtained from the species-
specific probe, and the bottom row of images shows HCR signal obtained from
the universal 16S probe. Figure 4.4b depicts the same set of experimental
samples but with sections taken from a mouse colonized singly with B. vulgatus.
As is evident qualitatively, these probes show species-specificity among these
four species, consistent with prior findings [25, 26]. For histogram analysis of
individual cells, refer to Appendix C.
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Figure 4.4: Species-specific detection of Bacteroides species by in situ
HCR. All samples were stained with Phalloidin488 (blue), an HCR probe tar-
geting a universal 16S sequence (green), and an HCR probe targeting a species-
specific region of 16S (red). Note red dots appear only when the probe is
matched to its appropriate cell line. This was conducted for colon tissue sec-
tions extracted from mice singly-colonized with each of B. fragilis (a) and B.
vulgatus (b). Probes: 1 single-initiator DNA probe per target. Amplifiers:
two orthogonal DNA HCR amplifiers carrying spectrally distinct fluorophores.
Sample: singly-colonized mouse colon tissue sections. Mice were colonized
with each B. fragilis and B. vulgatus prior to sectioning.
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4.5 Histogram Analysis of Single Bacterial Cells in Mouse Colon Tissue
Sections
In reference to Figure 4.6, Figure 4.5 details histogram analysis of individual
bacterial cells in the mouse colon tissue sections. 4.5a corresponds to B. fragilis
cells, and 4.5b to B. vulgatus cells stained within a dual-colonized mouse.
Signal is extracted by applying a threshold mask to raw data. Background is
extracted by applying the mask generated from images of the first species to
images of the second species. This ensures that the background corresponds to
bacterial cells, rather than slide background or mouse cells. Signal histograms
between replicates show variability due to the number and intensity of signal ob-
served between bacterial cells. Regardless, all histograms show near-complete
separation from background.
B. fragilis Background
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Cell 2
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nt
Fluorescence intensity
0 2048
B. vulgatus
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0 2048
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a
b
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Figure 4.5: Histogram analysis of single cells in mouse colon tissue sec-
tions. Sample: Mouse colon tissue sections dual-colonized with B. fragilis and
B. vulgatus. Probes: one single-initiator DNA probe per target. Amplifiers:
two orthogonal HCR amplifiers carrying spectrally distinct fluorophores.
Target Species Signal Background Signal-to-Background
B. fragilis 1,000 ± 500 60 ± 50 20 ± 20
B. vulgatus 3,000 ± 900 60 ± 40 50 ± 30
Table 4.1: Signal-to-background calculation for individual species. Calcu-
lations made using data extracted from images in Figure 4.5.
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4.6 Multiplexed Discrimination of Bacteroides Species in Mouse Colon
Tissue Sections
Though the multiplexed target detection demonstrated in Figure 4.4 is an ad-
vancement relative to prior direct-labeled probe fluorescent in situ hybridization
techniques due to HCR’s high signal-to-background, we sought to extend our
multiplexing ability to discriminate multiples species within a mouse colonized
with multiple Bacteroides species. Figure 4.6 demonstrates multiplexed detec-
tion of all bacteria, B. fragilis, and B. vulgatus in mouse colon tissue sections.
Additionally, Table 4.2 shows the high signal-to-background generated by HCR
amplification.
Universal 16S
B. fragilis
B. vulgatus
Composite
5 μM
Figure 4.6: Multiplexed mapping of Bacteroides species in fresh frozen,
fixed mouse colon tissue sections. Bacteroides localization within crypts
along mouse colon wall. Probes targeting the universal 16S (left, yellow) and
the two species (right, green and red) were added to the sample and ampli-
fied via HCR. Probes: 1 single-initiator DNA probe per target. Amplifiers:
three orthogonal DNA HCR amplifiers carrying spectrally distinct fluorophores.
Sample: dual-colonized mouse colon tissue sections. Mouse was colonized with
both B. fragilis and B. vulgatus prior to sectioning.
Target Species Signal Background Signal-to-Background
B. fragilis 1,000 ± 40 200 ± 10 5 ± 0.3
B. vulgatus 3,000 ± 100 500 ± 30 6 ± 0.4
Table 4.2: Signal-to-background analysis for individual targets. Calculations
made using data extracted from images depicted in Figure 4.6. See Appendix
C for image processing and calculation details.
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4.7 Conclusion
The work presented here lays the groundwork for expanding multiplexed de-
tection of closely related RNA targets in challenging samples. Specifically, we
demonstrate multiplexed detection of two Bacteroides species within intact
mouse colon tissue sections, along with a rigorous battery of control samples.
Additionally, the sharp signal localization conferred by HCR amplification allows
for the potential to localize bacteria within the mouse colon (e.g. differentiate
between bacteria in crypts versus in mucus).
When coupled with spectral imaging and linear unmixing, optimized in situ HCR
using short probes could allow for the immediate multiplexing of up to six flu-
orophores with high signal-to-background. Such a high degree of multiplexing
would allow biologists to gain fresh perspective on how bacterial localization
within the colon influences the environment.
58
4.8 Future Directions
Future work is planned in a few areas. First, it is important to expand our
multiplexing ability. In order to validate highly multiplexed detection of bacterial
species within the mouse colon, a range of control samples are required. We
hope to demonstrate multiplexed discrimination of four Bacteroides species
within the intact mouse colon sections.
Second, as shown in Chapters 2 and 3, HCR amplification allows for the de-
tection of mRNA and microRNA targets. It should be possible to incorporate
these kinds of RNA targets also. The techniques presented here combine to
form a broad set of tools for detecting all types of RNA elements in a typical
gene circuit. We have demonstrated detection of these elements (mRNA and
microRNA), as well as employed detection to allow for species discrimination
(via rRNA detection).
Third, that bacteria do not appear to co-localize spatially is suggestive that
hyper-multiplexing may be possible using spatial or temporal barcoding of flu-
orophores [29, 30]. Standard in situ HCR enables straightforward multiplexing
of n fluorophores, where n is the number of resolvable fluorescent dyes. Com-
pared to this, temporal barcoding with r rounds allows for multiplexing of up to
nr fluorescent dyes. For example, with n = 4 dyes and r = 3 rounds, up to 64
targets can be multiplexed. This would potentially enable the discrimination of
many closely-related species of bacteria.
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A p p e n d i x A
SUPPLEMENTARY INFORMATION FOR CHAPTER II
A.1 Materials and Methods
A.1.1 Cell Maintenance and Preparation
Three cell lines were used in this study: the wild-type HEK293T line and
two transgenic lines, HEK293 + d2egfp (Tg(d2egfp)) and HEK293 + dsRed2
(Tg(dsRed2)), which express d2egfp and dsRed2 mRNAs, respectively. HEK293T
cell line was obtained from ATCC, HEK293 + d2egfp was gifted by Dr. Christo-
pher Beisel (NIH), and HEK293 + dsRed2 was created using wild-type HEK293
(ATCC) and the pdsRed2-C1 expression vector (Clontech). Due to imperfect
vector integration process, the HEK293 + dsRed2 contains a small fraction of
wild-type cells. Transgenic protein fluorescence was confirmed by flow cytom-
etry (data not shown).
A.1.2 HCR Probes and Amplifiers
RNA HCR probes are 174-nt long (4x (26-nt initiator, 5-nt spacer) + 50-
nt mRNA recognition sequence). mRNA targets are addressed by probe sets
containing one or more probes that hybridize at 50-nt binding sites. RNA probes
were received in individual aliquots resuspended in ultrapure water, normalized
to a concentration of 1 µM.
RNA HCR amplifiers are 52-nt long hairpins (10-nt toehold, 16-bp stem, 10-nt
loop). RNA HCR amplifiers were conjugated to appropriate fluorophores (Life
Technologies Alexa Fluor R© Dyes, heretofore referred to as AlexaNNN to de-
note the dye’s excitation wavelength). Hairpin pairs were received as individual
aliquots resuspended in ultrapure water, normalized to a concentration of 3
µM.
For each target mRNA, a kit containing an RNA probe set, an RNA HCR
amplifier, and hybridization, wash, and amplification buffers was purchased
from Molecular Instruments (www.molecularinstruments.org). See Table A.1
for a summary of probe set, amplifier, and fluorophore details and Section A.4
for probe sequences.
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A.1.3 Experimental Design
All protocols and reagents can be found in Appendix A.3. All probe and amplifier
sequences can be found in Appendix A.4.
Figure 2.6a includes wild-type cells (background) and Tg(d2egfp) cells (signal
+ background). A single HCR probe was used along with the A3 HCR amplifier
conjugated to Alexa647. Figure 2.6b includes wild-type cells (background) and
Tg(dsRed2) cells (signal + background). A single HCR probe was used along
with the A3 HCR amplifier conjugated to Alexa647.
Figure 2.8 is composed of varying mixtures of wild-type and transgenic cells.
For each transgene, 5 mixtures were artificially created after fixation and per-
meabilization but before HCR. These mixtures were created by volume and
do not necessarily relate to total cell count. Mixtures included wild-type only,
transgene only, and the following ratios of wild-type to transgene: 1:1, 1:3,
and 3:1. For 2.8a, d2egfp was detected with a single HCR probe, and for 2.8b,
dsRed2 was also detected with a single HCR probe. The A3 HCR amplifier
conjugated to Alexa647 was used in both cases.
Figure ?? includes only transgenic cells. For each transgene, two orthogonal
probe sets and HCR amplifiers were used to perform redundant detection of
the mRNA target. For ??a, d2egfp was redundantly detected with: one HCR
probe initiating the A3 HCR amplifier (conjugated to Alexa488) and three
HCR probes initiating the A2 HCR amplifier (conjugated to Alexa647). For
??b, dsRed2 was redundantly detected with: three HCR probes initiating the
A3 HCR amplifier (conjugated to Alexa488) and two HCR probes initiating the
A5 HCR amplifier (conjugated to Alexa647).
Figure 2.13a is made up of individual cell lines. Figure 2.13b is composed of a
mixture of all cell lines (wild-type and both transgenes). Figure 2.13c is analysis
of the cells sorted using the gating indicated in 2.13b (quadrants). Tg(d2egfp)
was detected with three HCR probes and the A3 HCR amplifier conjugated to
Alexa647. Tg(dsRed2) was detected with three HCR probes and the A5 HCR
amplifier conjugated to Alexa488.
A.1.4 Flow Cytometry
Transgenic and wild-type cell lines were checked for protein fluorescence on
the BD AccuriTM C6. For detection of d2egfp (laser 488 nm, filter 533 ±
65
30 nm) and dsRed2 (laser 488 nm, filter 585 ± 40 nm), protein fluorescence
was compared between all three cell lines to verify protein presence in the
appropriate samples (data not shown).
Similarly, protein fluorescence was determined to be denatured after the HCR
protocol was completed due to the chemical and heat treatment. Cells were
resuspended in 500 µL 1x PBS following the in situ protocol. Acquisition for
Figures 2.6-?? was completed on the BD AccuriTM C6 for the detection of
the Alexa488- (laser 488 nm, filter 533 ± 30) and Alexa647-labeled (laser 640
nm, filter 675 ± 25 nm) HCR amplifiers. For each sample, 50,000 events were
counted within the selected gate (based on forward and side scatters to filter
out debris).
A.1.5 Fluorescence Activated Cell Sorting
Cell sorting for Figure 2.13 was performed using a BD FACSAriaTM I located
at University of Southern California’s Flow Cytometry Core Facility. HCR am-
plifiers were detected with both Alexa488- (laser 488 nm, PMT 2D, mirror
505 LP, filter 510 ± 20) and Alexa647-labels (laser 633 nm, PMT 4C, filter
660 ± 20). Sorted cells were deposited into 1.7 mL micro-centrifuge tubes
and re-analyzed on the same machine for checking purity. Entire samples were
sorted, and approximately 10,000 cells were analyzed.
A.1.6 Statistical Analysis
All plots were created and statistical analyses completed using MATLAB R©.
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A.2 Technical Replicates
This section contains technical replicates for all figures presented in Chapter
2. Technical replicates refer to in situ HCR performance; biological samples
are taken from the same batch of prepared cell lines to maintain consistency.
A.2.1 Single Color Validation of in situ HCR
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Figure A.1: Technical replicates corresponding to Figure 2.6. Samples:
HEK293T, HEK293 + d2egfp, HEK293 + dsRed2. Targets: transgenic mR-
NAs: (a) Tg(d2egfp) and (b) Tg(dsRed2). Probe sets: single HCR probe per
target. Due to impurities in the vector integration process, a small population
of wild-type cells are observed in the Tg(dsRed2) cell line. Each histogram is
composed of 50,000 cells.
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Figure A.2: Technical replicates corresponding to Figure 2.7. Samples:
HEK293T, HEK293 + d2egfp, HEK293 + dsRed2. Targets: transgenic mR-
NAs: (a) Tg(d2egfp) and (b) Tg(dsRed2). Probe sets: single HCR probe per
target. Due to impurities in the vector integration process, a small population
of wild-type cells are observed in the Tg(dsRed2) cell line. Each histogram is
composed of 50,000 cells.
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A.2.2 Single Color Validation of in situ HCR with Heterogeneous Mix-
tures
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Figure A.3: Technical replicates corresponding to Figure 2.8. Cell lines:
HEK293T, HEK293 + d2egfp, HEK293 + dsRed2. Targets: transgenic mR-
NAs: (a) Tg(d2egfp) and (b) Tg(dsRed2). Probe sets: single HCR probe per
target. Due to impurities in the vector integration process, a small population
of wild-type cells are observable in the 100% Tg(dsRed2) sample and con-
tribute to all mixtures of wild-type and Tg(dsRed2) cells. Each histogram is
composed of 50,000 cells.
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Figure A.4: Technical replicates corresponding to Figure 2.9. Cell lines:
HEK293T, HEK293 + d2egfp, HEK293 + dsRed2. Targets: transgenic mR-
NAs: (a) Tg(d2egfp) and (b) Tg(dsRed2). Probe sets: single HCR probe per
target. Due to impurities in the vector integration process, a small population
of wild-type cells are observable in the 100% Tg(dsRed2) sample and con-
tribute to all mixtures of wild-type and Tg(dsRed2) cells. Each histogram is
composed of 50,000 cells.
70
A.2.3 Relative Quantitation of mRNA Abundance by Redundant Detec-
tion
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Figure A.5: Technical replicates corresponding to Figure 2.11. Samples:
HEK293 + d2egfp, HEK293 + dsRed2. Targets: transgenic mRNAs: (a)
Tg(d2egfp) and (b) Tg(dsRed2). Probe sets: (a) three HCR probes for channel
1, single HCR probe for channel 2 and (b) two HCR probes for channel 1, three
HCR probes for channel 2. Due to impurities in the vector integration process,
a small population of wild-type cells are observable in the Tg(dsRed2) cell line
(cluster near origin in (b)).
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Figure A.6: Technical replicates corresponding to Figure 2.12. Samples:
HEK293 + d2egfp, HEK293 + dsRed2. Targets: transgenic mRNAs: (a)
Tg(d2egfp) and (b) Tg(dsRed2). Probe sets: (a) three HCR probes for channel
1, single HCR probe for channel 2 and (b) two HCR probes for channel 1, three
HCR probes for channel 2. Due to impurities in the vector integration process,
a small population of wild-type cells are observable in the Tg(dsRed2) cell line
(cluster near origin in (b)).
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A.3 Protocols
A.3.1 Media Preparation
Growth Media
1. Heat inactivate a bottle of FBS at 50 ◦C for 30 m and aliquot the bottle
into 50 mL Falcon tubes.
2. Remove 50 mL of media from fresh 500 mL bottle of Dulbecco’s Eagle
Modified Medium (DMEM).
3. Add 50 mL of FBS for 10% final concentration.
4. Media must be pre-warmed to 37 ◦C prior to adding to live cells1.
Cell Freezing Media
• 90% growth media
• 10% dimethyl sulfoxide (DMSO)
A.3.2 Cell Thawing
1. Add 9 mL of warmed (37 ◦C) growth medium to a 15 mL Falcon tube.
2. Thaw frozen cells by placing cryogenic storage vial in 37 ◦C water bath
with floating styrofoam.
3. Remove the tube when cells begin to thaw (≈ 2 m).
4. Add 1 mL growth medium to melt ice completely.
5. Transfer cells back to 15 mL tube (making 10 mL total).
6. Centrifuge for 5 m at 1.0 RCF (relative centrifugal force) to remove
DMSO.
7. Aspirate supernatant carefully.
8. Add 0.5 mL growth medium to resuspend cell pellet.
9. Add 9.5 mL growth medium to 10 cm cell culture plate.
1Be sure to make fresh media every 1-2 months.
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10. Add 0.5 mL cells in growth medium to cell culture plate.
11. Store plate at 37 ◦C.
A.3.3 Cell Passaging
1. Warm up trypsin, phosphate buffered saline (PBS), and growth medium
to 37 ◦C.
2. Remove culture plate from 37 ◦C incubator.
3. Wash plate with 5 mL PBS.
4. Add 3 mL trypsin to detach cells.
5. Incubate plate for 5 m at 37 ◦C.
6. Add 3 mL growth medium to quench trypsin.
7. Transfer cells to 15 mL Falcon tube.
8. Centrifuge for 5 m at 1.0 RCF.
9. Aspirate medium, and resuspend cells in 10 mL fresh growth medium.
10. Add 0.5 mL cells to 9.5 mL in fresh cell culture plate.
11. Store plate at 37 ◦C.
A.3.4 Cell Freezing
1. Grow four extra plates of cell line.
2. Prepare 5 mL freezing medium.
3. Follow steps 1-8 from cell passaging protocol.
4. Instead of growth medium, resuspend cells in freezing medium2.
5. Aliquot cells in freezing medium into 5 cryogenic storage vials.
6. Place vials in styrofoam box inside -80 ◦C to slowly chill cells.
7. After 16 h, move cells into liquid nitrogen for long-term storage.
2Be sure to begin freezing process within 5 m of adding DMSO to cells
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A.3.5 Cell Fixation
Follow steps 1-8 from cell passaging protocol.
1. Aspirate, and resuspend cells in 20 mL growth medium.
2. Centrifuge for 5 m at 1.0 RCF.
3. Aspirate, and resuspend cells in freshly made 4% PFA in PBST.
4. Fix for 1 h at RT.
5. Centrifuge for 5 m at 1.0 RCF.
6. Aspirate, and resuspend cells in 10 mL PBST.
7. Repeat previous two steps two more times.
8. Aspirate, and resuspend cells in 10 mL 70% ethanol.
9. Store overnight at 4 ◦C.
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A.3.6 Multiplexed in situ Hybridization Chain Reaction in Cell Culture
Detection Stage
1. For each sample, move ≈500,000 cells to a 1.5 mL eppendorf tube.
2. Pre-hybridize with 100 µL of 50% hybridization buffer (HB50) for 10 min
at 55 ◦C.
3. Prepare probe solution by adding 10 pmol of each probe (1 µL of 10 µM
stock per probe) to 400 µL of HB50 at 55 ◦C.
4. Add the probe solution directly to samples in HB50.
5. Incubate samples 4 h at 55 ◦C.
6. Remove excess probes by washing at 55 ◦C with 1 mL of:
a) HB50 for 30 min
b) HB50 for 30 min
Solutions should be pre-heated to 55 ◦C before use. Remove HB50 be-
tween washes by centrifugation (5 m at 1.0 RCF).
Amplification Stage
1. Pre-amplify samples with 100 µL of 40% hybridization buffer (HB40) for
10 min at 45 ◦C.
2. Prepare 30 pmol of each fluorescently-labeled hairpin by snap cooling in
10 µL of 5× SSC buffer (heat at 95 ◦C for 90 seconds and cool to room
temperature on the benchtop for 30 min).
3. Prepare hairpin solution by adding all snap-cooled hairpins to 400 µL of
HB40 at 45 ◦C.
4. Add the hairpin solution directly to samples in HB40.
5. Incubate samples overnight (12–16 h) at 45 ◦C.
6. Remove excess hairpins by washing with at 45 ◦C with 1 mL of:
a) 75% HB40 and 25% 2× SSCT for 5 m
76
b) 50% HB40 and 50% 2× SSCT for 5 m
c) 25% HB40 and 75% 2× SSCT for 5 m
d) 100% 2× SSCT for 5 m
7. Resuspend in 2× SSCT at RT.
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A.3.7 Buffer Recipes
Cell Growth Media For 500 mL of solution
10% fetal bovine serum (FBS) 50 mL of FBS
1× penicillin streptomycin (pen
strep)
5 mL 100× pen strep
Fill up to 500 mL with Dulbecco’s
Modified Eagle Medium
PBST For 50 mL of solution
1× PBS 5 mL of 10× PBS
0.1% Tween 20 500 µL of 10% Tween 20
Fill up to 50 mL with ultrapure H2O
4% Formaldehyde (FA) For 40 mL of solution
4% FA 10 mL 16% methanol-free FA
1× PBST 30 mL of 1× PBST
50% Hybridization Buffer (HB50) For 40 mL of solution
50% Formamide 20 mL of Formamide
2× Sodium Chloride Sodium Citrate
(SSC)
4 mL of 20× SSC
9 mM Citric Acid (pH 6.0) 360 µL of 1 M Citric Acid (pH 6.0)
0.1% Tween 20 400 µL of 10% Tween 20
500 µg/mL tRNA 200 µL of 100 mg/mL tRNA
50 µg/mL Heparin 200 µL of 10 mg/mL Heparin
Fill up to 40 mL with ultrapure H2O
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40% Hybridization Buffer (HB40) For 40 mL of solution
40% Formamide 16 mL of Formamide
2× Sodium Chloride Sodium Citrate
(SSC)
4 mL of 20× SSC
9 mM Citric Acid (pH 6.0) 360 µL of 1 M Citric Acid (pH 6.0)
0.1% Tween 20 400 µL of 10% Tween 20
500 µg/mL tRNA 200 µL of 100 mg/mL tRNA
50 µg/mL Heparin 200 µL of 10 mg/mL Heparin
Fill up to 50 mL with ultrapure H2O
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A.3.8 Reagents and Supplies
Dimethyl sulfoxide (DMSO) (Sigma Aldrich Cat. # D8418)
Dulbecco’s Modified Eagle Medium (DMEM) (Thermo Fisher Cat. # 11995-
065)
Dulbecco’s Phosphate Buffered Saline (DPBS) (Thermo Fisher Cat. # 14190-
094)
Fetal Bovine Serum (FBS) (Thermo Fisher Cat. # 16140-071)
Formaldehyde (16%) (Polysciences Cat. # 18814-10)
HCR Amplifiers and Buffers (Molecular Instruments)
Penicillin Streptomycin (Pen Strep) (Thermo Fisher Cat. # 15140-122)
Round Bottom Test Tubes (Flow Cytometry) (VWR Cat. # 21008-948)
Trypsin-EDTA (0.25%) (Thermo Fisher Cat. # 25200-072)
10× Phosphate-buffered saline (PBS) (Ambion Cat. # AM9625)
20× Sodium chloride sodium citrate (SSC) (Invitrogen Cat. # 15557-044)
50% Tween 20 (Invitrogen Cat. # 00-3005)
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A.4 Sequences
A.4.1 Probe Sequences
Sequences for all target mRNAs used in this paper were obtained from the
Universal Protein Resource (UniProt) and Addgene. All sequences are listed
5′ to 3′. For full quad-initiator probe sequences, four repeat initiator + spacer
sequences were appended to the 5′ end of the probe sequence. For brevity, full
probe sequences are not shown.
Target: beta actin (actb)
Probe # Probe Sequence
1 CCgACUgCUgUCACCUUCACCgUUCCAgUUUUUAAAUCCUgAgUCAAgCC
2 CAAUgUgCAAUCAAAgUCCUCggCCACAUUgUgAACUUUgggggAUgCUC
3 CCAUUCUCCUUAgAgAgAAgUggggUggCUUUUAggAUggCAAgggACUU
4 AUUUACACgAAAgCAAUgCUAUCACCUCCCCUgUgUggACUUgggAgAgg
5 CACUCCCAgggAgACCAAAAgCCUUCAUACAUCUCAAgUUgggggACAAA
6 UUUAUUCAACUggUCUCAAgUCAgUgUACAggUAAgCCCUggCUgCCUCC
Table A.2: Probe sequences targeting mammalian mRNA transcript: actb
Target: destabilized enhanced green fluorescent protein # 2 (d2egfp)
Probe # Probe Sequence
1 gUUCUUCUgCUUgUCggCCAUgAUAUAgACgUUgUggCUgUUgUAgUUgU
4 ACgCUgCCgUCCUCgAUgUUgUggCggAUCUUgAAgUUCACCUUgAUgCC
7 gCgggUCUUgUAgUUgCCgUCgUCCUUgAAgAAgAUggUgCgCUCCUggA
8 CgUAgCCUUCgggCAUggCggACUUgAAgAAgUCgUgCUgCUUCAUgUgg
10 ggUgggCCAgggCACgggCAgCUUgCCggUggUgCAgAUgAACUUCAggg
Table A.3: Probe sequences targeting mRNA transcript: d2egfp
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Target: optimized red fluorescent protein (dsRed2)
Probe # Probe Sequence
1 AAgUUCAUCACgCgCUCCCACUUgAAgCCCUCggggAAggACAgCUUCUU
2 gAAgUUCACgCCgAUgAACUUCACCUUgUAgAUgAAgCAgCCgUCCUgCA
4 gACUUgAACUCCACCAggUAgUggCCgCCgUCCUUCAgCUUCAgggCCUU
5 CCACgUAgUAgUAgCCgggCAgCUgCACgggCUUCUUggCCAUgUAgAU
6 ggUACCgUCgACUgCAgAAUUCgAAgCUUgAgCUCgAgAUCUCAggAACA
Table A.4: Probe sequences targeting mRNA transcript: dsRed2
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A.4.2 Amplifier Sequences
Sequences for RNA HCR initiators were obtained from Molecular Instruments
(MI). All sequences are listed 5′ to 3′.
System # Initiator Spacer
A2 gACCCUAAgCAUACAUCgUCCUUCAU UUUUU
A3 gACUACUgAUAACUggAUUgCCUUAg AAUUU
A5 UACgCCCUAAgAAUCCgAACCCUAUg AAAUA
Table A.5: RNA HCR initiator sequences
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A p p e n d i x B
SUPPLEMENTARY INFORMATION FOR CHAPTER III
B.1 Materials and Methods
B.1.1 HCR Probes and Amplifiers
For each target miRNA, probes were ordered as chimeric 2’-O-methylated RNA
sequences appended by the appropriate DNA HCR initiator sequence from In-
tegrated DNA Technologies (www.idtdna.com). For each target mRNA, a
kit containing a DNA probe set, a DNA HCR amplifier, and hybridization,
wash, and amplification buffers was purchased from Molecular Instruments
(www.molecularinstruments.org). See Table B.1 for a summary of probe set,
amplifier, and fluorophore details and Appendix B.6 for probe sequences.
Target Type Target Probes HCR Amplifier Fluorophore Figures
mRNA hbae3 7 B1 Alexa546 3.3, 3.4, B.2-B.3
microRNA miR-9 1 B3 Alexa488 3.3, 3.4, B.2-B.3
miR-96 1 B4 Alexa647 3.3, 3.4, B.2-B.3
miR-206 1 B2 Alexa514 3.3, 3.4, B.2-B.3
1 B1 Alexa647 B.1
miR-10 1 B1 Alexa647 B.1
miR-144 1 B1 Alexa647 B.1
Table B.1: Probe set, HCR amplifier, and fluorophore for each target.
B.1.2 Experimental Design
Procedures for the care and use of zebrafish embryos were approved by the
Caltech IACUC. Embryos were fixed and permeabilized using the protocol of
Sections B.5.1. In situ hybridization experiments were performed using the
protocols of Section B.5.2. Samples were mounted for imaging as described
also in Section B.5.2.
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B.1.3 Standard Confocal Microscopy
A Zeiss 710 NLO inverted confocal microscope was used to image whole-
mount embryos and larva. An LD LCI Plan-Apochromat 25x/0.8 Imm Korr
DIC objective was used to acquire all images. See Table B.2 for a summary
of excitation laser sources, beam splitters, and tuned emission bandpass filters
used for each target when using standard confocal microscopy.
Target Fluorophore Laser (nm) Beam Splitter Filter (nm) Figure
hbae3 Alexa647 633 488/561/633 638–755 3.2
miR-9 Alexa546 561 458/561 563–641 3.2
miR-96 Alexa488 488 488/561/633 493–530 3.2
miR-206 Alexa514 514 458/514 534–563 3.2
Alexa647 647 488/561/633 638–755 B.1
miR-10 Alexa647 647 488/561/633 638–755 B.1
miR-144 Alexa647 647 488/561/633 638–755 B.1
Table B.2: Standard confocal microscopy settings for each target.
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B.1.5 Image Analysis
Image analysis protocols have been outlined in previous work [1]. For each
target miRNA/mRNA, background (BACK) is characterized for pixels in one
representative region without gene expression, and signal plus background (SIG
+ BACK) is characterized for pixels in one representative region with high gene
expression (Figures 3.4a, B.1b). For pixels within these regions, distributions
are characterized by plotting pixel intensity histograms (Figure 3.4b, B.1c)
and characterize performance by calculating mean pixel intensity (xBACK and
xSIG+BACK). Performance across technical replicates (N = 3 for each tar-
get in Figure 3.4) is characterized by calculating sample means (x¯BACK and
x¯SIG+BACK) and sample standard deviations (σBACK and σSIG+BACK) (See Ta-
ble 3.3). The mean signal is then estimated as (Equation B.1):
x¯SIG = x¯SIG+BACK − x¯BACK (B.1)
and the standard deviation, accounting for the propagation of uncertainty as
(Equation B.2):
σSIG ≤
√
σ2SIG+BACK + σ
2
BACK. (B.2)
Then, the result from Equation B.1 is used to calculate signal-to-background
(Equation B.3):
x¯SB =
x¯SIG
x¯BACK
(B.3)
with standard deviation, accounting for the propagation uncertainty as (Equa-
tion B.4):
σSB ≤ x¯SB ·
√(
σSIG
x¯SIG
)2
+
(
σBACK
x¯BACK
)2
(B.4)
Estimates for background (x¯BACK ± σBACK), signal (x¯SIG ± σSIG), and signal-
to-background (x¯SB ± σSB) are displayed for each target miRNA/mRNA in
Table 3.3.
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For Figure 3.2, autofluorescence in characterized for pixels in a representative
region within blood vessels. Pixels in these regions are analyzed as outlined
previously. Figure 3.2a demonstrates these representative regions and the cor-
responding histograms. See Table 3.2 for quantitative comparisons.
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B.2 MicroRNA Detection in Early Stage Embryos
Experiments were also performed using younger zebrafish embryos (26 hpf).
For these embryos, the protocol outlined in Section B.5 was used, but pro-
teinase K digestion was not required. Figure B.1 demonstrates a minimal set
of in situ HCR images and analysis of microRNA targets expressing at this
younger stage. It also serves to show the flexibility of the protocol with respect
to sample stage and tissue complexity.
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Figure B.1: MicroRNA detection with early stage zebrafish embryos. a.
Traditional in situ images of three microRNA targets. b. In situ HCR images
of three microRNA target. c. Histogram analysis of HCR images. Solid box in
(b) indicates "Signal + Background" and dotted box indicates "Background."
Sample: Wild-type zebrafish fixed at 26 hpf. Probes: one single-initiator DNA
probe per target.
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B.3 Reference Images for microRNA Targets
Reference images were obtained for each microRNA target studied from prior
work in the field[2]. HCR images were compared to these reference images to
ensure competitive and correct target staining. Figure B.2 depicts traditional
in situ images for each microRNA target detected alongside respective signal
obtained with in situ HCR.
miR-96
miR-206
miR-9
Figure B.2: Reference images for microRNA targets. Images in right column
are maximum intensity projections of images obtained via spectral confocal
microscopy and processed with linear unmixing. Sample: Casper zebrafish fixed
at 72 hpf. Probes: one single-initiator DNA probe per target.
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B.4 Reference Spectra for Alexa Fluor Dyes
In order to determine which dyes would require linear unmixing, we spectrally
imaged each dye of interest, exciting with each laser source of interest. Figure
B.3 shows the spectral overlap of the dyes used, as well as the extent to which
each dye is excited by various excitation sources.
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Figure B.3: Observed emission spectra for embryo autofluorescence and
Alexa Fluor dyes. Plots depict acquired emission spectra for embryo autoflu-
orescence and four Alexa Fluor dyes, excited with each of four laser sources.
Additionally, Table B.4 quantifies the observed excitation of efficiency depicted
in Figure B.3. Histograms are integrated and normalized to the emission ob-
served with a dye’s optimal laser source (e.g. Alexa Fluor 488 excited by a 488
nm laser source). Data suggests Alexa Fluor 546 and Alexa Fluor 647 do not
require unmixing in their respective channels. Imaging Alexa Fluor 488 and 514
requires linear unmixing.
Dye/Excitation 488 nm 514 nm 561 nm 633 nm
Alexa Fluor 488 100% 93% 17% 1%
Alexa Fluor 514 7% 100% 37% 2%
Alexa Fluor 546 <1% <1% 100% 12%
Alexa Fluor 647 <1% <1% <1% 100%
Table B.4: Excitation efficiency of source and dye pairs. Columns refer to
excitation source and rows refer to specific dye. Data in fields represent the
efficiency relative to the optimal source/dye pair (e.g. 488 nm laser exciting
Alexa Fluor 488).
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B.5 Protocols
B.5.1 Preparation of Fixed Whole-Mount Zebrafish Embryos
1. Collect embryos and incubate at 28 ◦C in a petri dish with egg H2O until
they reach 70 hr post-fertilization (70 hpf).
2. Transfer ∼80 embryos (72 hpf) to a 2 mL eppendorf tube and remove
excess egg H2O.
3. Fix embryos in 1 mL of 4% paraformaldehyde (PFA)1 for 24 hr at 4 ◦C .
4. Wash embryos 3 × 5 min with 1 mL of 1× phosphate-buffered saline
(PBS) to stop the fixation. Fixed embryos can be stored at 4 ◦C at this
point.
5. Dehydrate and permeabilize with a series of methanol (MeOH) washes
(1 mL each):
a) 100% MeOH for 4 × 10 min
b) 100% MeOH for 1 × 50 min.
6. Rehydrate with a series of graded 1 mL MeOH/PBST washes for 5 min
each:
a) 75% MeOH / 25% PBST
b) 50% MeOH / 50% PBST
c) 25% MeOH / 75% PBST
d) 5 × 100% PBST.
7. Digest embryos with 1 µg/mL proteinase K for 15 min2.
8. Immediately post-fix embryos in 4% PFA for 20 min3.
9. Wash embryos 5 × 5 min with 1 mL of tris-buffered saline (TBST) to
stop the fixation and wash out phosphate.
10. Wash embryos 3 × 15 min with 1 mL of 1-Methylimidazole buffer (1-
MIB).
1Use fresh PFA to avoid increased autofluorescence.
2Be sure to optimize exact proteinase K digestion conditions per batch.
3PFA made earlier can be reused during post-fixation.
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11. Fix embryos in 1 mL of 0.16 M 1-ethyl-3-(3-dimethylaminopropyl) car-
bodiimide (EDC) in 1-MIB4 for 2 hr at RT.
12. Wash embryos 4 × 5 min with 1 mL TBST.
13. Store embryos at 4 ◦C before use5.
4Add dry EDC to 1-MIB immediately before adding to sample.
5Prepare embryos every two weeks to avoid increased autofluorescence.
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B.5.2 Multiplexed in situ Hybridization Chain Reaction
Detection stage
1. For each sample, move 8 embryos to a 1.5 mL eppendorf tube.
2. Pre-hybridize with 500 µL of probe hybridization buffer for 30 min at 45
◦C.
3. Prepare probe solution by adding 1 pmol of each probe (1 µL of 1 µM
stock per probe) to 500 µL of probe hybridization buffer at 45 ◦C.
4. Remove the pre-hybridization solution and add the probe solution.
5. Incubate the embryos overnight (12–16 hr) at 45 ◦C.
6. Remove excess probes by washing at 45 ◦C with 500 µL of:
a) 75% of probe wash buffer / 25% 5× SSCT for 15 min
b) 50% of probe wash buffer / 50% 5× SSCT for 15 min
c) 25% of probe wash buffer / 75% 5× SSCT for 15 min
d) 100% 5× SSCT for 15 min
e) 100% 5× SSCT for 30 min.
Wash solutions should be pre-heated to 45 ◦C before use.
Amplification stage
1. Pre-amplify embryos with 500 µL of amplification buffer for 30 min at
room temperature.
2. Prepare 30 pmol of each fluorescently-labeled hairpin by snap cooling in
10 µL of 5× SSC buffer (heat at 95 ◦C for 90 seconds and cool to room
temperature on the benchtop for 30 min).
3. Prepare hairpin solution by adding all snap-cooled hairpins to 500 µL of
amplification buffer at room temperature.
4. Remove the pre-amplification solution and add the hairpin solution.
5. Incubate the embryos overnight (12–16 hr) at room temperature.
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6. Remove excess hairpins by washing with 500 µL of 5× SSCT at room
temperature:
a) 2 × 5 min
b) 2 × 30 min
c) 1 × 5 min
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B.5.3 Buffer Recipes
4% Paraformaldehyde (PFA) For 25 mL of solution
4% PFA 1 g of PFA powder
1× PBS 25 mL of 1× PBS
PBST For 50 mL of solution
1× PBS 5 mL of 10× PBS
0.1% Tween 20 500 µL of 10% Tween 20
Fill up to 50 mL with ultrapure H2O
TBST For 50 mL of solution
1× TBS 5 mL of 10× TBS
0.1% Tween 20 500 µL of 10% Tween 20
Fill up to 50 mL with ultrapure H2O
1-Methylimidazole buffer (1-MIB) For 20 mL of solution
300 mM NaCl 2 mL of 3M NaCl
0.13 M 1-methylimidazole 200 µL 1-methylimidazole
Add 56 µL 12 M HCl to pH 8.0
Fill up to 20 mL with ultrapure H2O
EDC fixation buffer6 For 10 mL of solution
0.16 M EDC 0.163 g EDC
Fill up to 10 mL with 1-MIB
6Prepare EDC fixation buffer immediately prior to use.
6Prepare EDC fixation buffer immediately prior to use.
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B.5.4 Reagents and Supplies
EDC (Thermo Scientific Pierce Cat. # PI22980)
HCR Amplifiers and Buffers (Molecular Instruments)
Hydrochloric Acid (HCl) (EMD Millipore Cat. # HX0603-75)
Methanol (Mallinckrodt Chemicals Cat. # 3016-16)
Paraformaldehyde (PFA, 16% methanol free) (Alfa Aesar Cat. # 43368)
Proteinase K solution (Ambion Cat. # AM2546)
1-Methylimidazole (MP Biomedicals, LLC Cat. # 0215165580)
10× Phosphate-buffered saline (PBS) (Ambion Cat. # AM9625)
20× Sodium chloride sodium citrate (SSC) (Invitrogen Cat. # 15557-044)
20× Tris-buffered saline (TBS) (Pierce Cat. # 28358)
22 mm × 50 mm No. 1 coverslip (VWR Cat. # 48393-048)
25 mm × 75 mm glass slide (VWR Cat. # 48300-025)
50% Tween 20 (Invitrogen Cat. # 00-3005)
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A p p e n d i x C
SUPPLEMENTARY INFORMATION FOR CHAPTER IV
C.1 Materials and Methods
C.1.1 HCR Probes and Amplifiers
Probes were ordered as DNA sequences appended by the appropriate DNA HCR
initiator sequence from Integrated DNA Technologies (www.idtdna.com). Kits
containing a DNA HCR amplifier and hybridization, wash, and amplification
buffers were purchased fromMolecular Instruments (www.molecularinstruments.org).
See Table C.1 for a summary of probe set, amplifier, and fluorophore details
and Appendix C.4 for probe sequences.
Target Type Target Organism HCR Amplifier Fluorophore Figures
16s rRNA All Bacteroides B1 Alexa488 4.6, 4.5, 4.3, C.1
None Alexa488 4.3
B1 Alexa546 4.4
None Alexa546 4.2
Bacteroides fragilis B3 Alexa647 4.4a, 4.6, 4.5
None Alexa647 4.2
Bacteroides ovatus None Alexa647 4.2
Bacteroides theta None Alexa647 4.2
Bacteroides vulgatus B2 Alexa546 4.6, 4.5
B2 Alexa647 4.4b
None Alexa647 4.2
Table C.1: Probe, HCR amplifier, and fluorophore for each Bacteroides species.
All targets detected with single probe each.
C.1.2 Experimental Design
Mice were handled and sectioned by trained personnel in the Mazmanian Lab
following IACUC guidelines. Fresh frozen colon tissue sections were fixed and
permeabilized using the protocol of Sections C.3.1. In situ hybridization ex-
periments were performed using the protocols of Section C.3.2. Samples were
prepared for imaging as described also in Section C.3.2.
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C.1.3 Microscopy
Images were acquired using either a ZEISS Axio Observer Z1 fluorescent micro-
scope or a ZEISS LSM 800 confocal microscope. For fluorescent microscopy
images, an EC Plan-NeoFluar 40x/0.75 Ph2 M27 objective was used with
1.6x Optovar for a final magnification of 64x. For confocal images, a Plan-
Apochromat 63x/1.40 Oil DIC M27 objective was used to acquire all images.
See Tables C.2 and C.3 for a summary of excitation sources, beam splitters,
and tuned emission bandpass filters used for each fluorophore on both types of
microscopes.
Fluorophore Excitation (nm) Beam Splitter (nm) Filter (nm)
Alexa546 545 ± 30 570 620 ± 60
Alexa647 640 ± 30 660 690 ± 50
Table C.2: Fluorescent microscope settings for each fluorophore channel.
Fluorophore Laser (nm) Beam Splitter (nm) Filter (nm)
Alexa405 405 None 400–450
Alexa488 488 488/561/633 490–530
Alexa546 561 488/561/633 561–580
Alexa647 633 488/561/633 645–700
Table C.3: Confocal microscope settings for each fluorophore channel.
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C.1.4 Image Analysis
Image analysis presented here is based upon aforementioned work (Appendix
B.1.5) [1]. For each acquired image, thresholds are applied using Otsu’s
method to automatically determine threshold by exhaustively searching for
the threshold that minimized intra-class variance in signal and background.
Once this threshold is applied, a binary mask is created. This binary mask is
used to extract pixels corresponding to signal plus background (SIG + BACK).
Background (BACK) is characterized for pixels in a representative region not
containing bacterial cells (as determined by universal 16S staining).
Once this data is extracted from images, calculations are performed similar to
those found in Appendix B.1.5.
Figure 4.5 demonstrates raw images and corresponding histograms obtained
from analysis. Estimates for background (x¯BACK ± σBACK), signal (x¯SIG ±
σSIG), and signal-to-background (x¯SB) are displayed for each target species in
Table 4.1.
Additionally, Figure 4.2 and related Table 4.2 demonstrate raw images and
quantitative analysis. Estimates for universal 16S (EUB) signal, species-specific
signal, and the normalized signal (discrimination ratio) are displayed for each
target species in Table 4.2.
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C.2 Comparison of Literature in situ vs Optimized HCR Protocol
Figure C.1 compares current methodology for short probe hybridization[3] com-
pared to optimized conditions presented in Appendix C.3. Key differences be-
tween the protocols include hybridization temperature, hybridization and wash
buffers, and wash protocol. Detailed descriptions of these can also be found in
Appendix C.3.3.
Literature hybridization conditions Optimized hybridization conditions
10 μM
Figure C.1: Comparing literature in situ protocol to optimized HCR pro-
tocol. Sample: Mouse colon tissue sections singly-colonized with B. frag-
ilis. Probe: one HCR probe targeting a universal 16S region amplified with
Alexa488-labeled HCR using literature conditions (left) versus optimized con-
ditions (right).
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C.3 Protocols
C.3.1 Preparation of Fresh Frozen Mouse Colon Tissue Sections
1. Remove slides from -80 ◦C, and allow to thaw and air dry to RT.
2. Wipe down slide as much as possible with Kimwipe without disturbing
sections.
3. Fix sections by placing slides in Coplin jar filled with 30 mL of 4%
paraformaldehyde (PFA)1 for 20 m at RT.
4. Remove fixative, and wash slides twice in PBST for 5 m at RT.
1Use fresh PFA to avoid increased autofluorescence.
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C.3.2 Multiplexed in situ Hybridization Chain Reaction
Detection stage
1. Pre-hybridize with 150 µL of 20% hybridization buffer for 1 h at 65 ◦C.
2. Prepare probe solution by adding 0.2 pmol of each probe (2 µL of 0.1
µM stock per probe) to 100 µL of 20% hybridization buffer at 37 ◦C.
3. Wipe down slide without disturbing tissue sections to remove the pre-
hybridization solution and add 75 µL of the probe solution.
4. Place cover slip over tissue sections to minimize evaporation.
5. Incubate slides overnight (12–16 hr) at 37 ◦C in a humidified chamber.
6. Gently remove the cover slip by immersing slide in a Coplin jar filled with
30 mL of 20% probe wash buffer at RT.
7. Remove excess probes by washing at 37 ◦C in a Coplin jar filled with 30
mL each of:
a) 75% of 20% probe wash buffer / 25% 5× SSCT for 15 min
b) 50% of 20% probe wash buffer / 50% 5× SSCT for 15 min
c) 25% of 20% probe wash buffer / 75% 5× SSCT for 15 min
d) 100% 5× SSCT for 15 min
Wash solutions should be pre-heated to 37 ◦C before use.
8. Immerse slides in 5× SSCT at RT for 5 m.
Amplification stage
1. Pre-amplify with 150 µL of amplification buffer for 1 h at RT.
2. Prepare 6 pmol of each fluorescently-labeled hairpin by snap cooling in
2 µL of 5× SSC buffer (heat at 95 ◦Cfor 90 seconds and cool to room
temperature on the benchtop for 30 min).
3. Prepare hairpin solution by adding all snap-cooled hairpins to 100 µL of
amplification buffer at RT.
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4. Wipe down slide without disturbing tissue sections to remove the pre-
amplification solution and add 75 µL of the hairpin solution.
5. Place cover slip over tissue sections to minimize evaporation.
6. Incubate slides overnight (12–16 hr) at RT in a humidified chamber.
7. Gently remove the cover slip by immersing slide in a Coplin jar filled with
30 mL of 5× SSCT at RT.
8. Remove excess amplifier by washing at RT in a Coplin jar filled with 30
mL each of:
a) 2 × 30 min
b) 1 × 5 min
Tissue Section Staining and Mounting
1. Prepare phalloidin staining buffer by diluting 1:40 stock into PBST.
2. Add 150 µL staining buffer to cover tissue sections on slide.
3. Incubate slides 1–24 h at RT in a humidified chamber.2
4. Remove staining buffer by washing twice at RT in a Coplin jar filled with
30 mL of 5× SSCT.
5. Wipe down slide without disturbing tissue sections to remove 5× SSCT.
6. Add 75 µL ProLong Gold mounting media to cover tissue sections, and
immediately place cover slip.
7. Slides can be stored in the dark at RT indefinitely.
2For longer incubation, consider using a cover slip to minimize evaporation.
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C.3.3 Buffer Recipes
4% Paraformaldehyde (PFA) For 40 mL of solution
4% PFA 10 mL of 16% Methanol-Free PFA
1× PBS 30 mL of 1× PBS
PBST For 50 mL of solution
1× PBS 5 mL of 10× PBS
0.1% Tween 20 500 µL of 10% Tween 20
Fill up to 50 mL with ultrapure H2O
SSCT For 50 mL of solution
5× Sodium Chloride Sodium Citrate
(SSC)
12.5 mL of 20× SSC
0.1% Tween 20 500 µL of 10% Tween 20
Fill up to 50 mL with ultrapure H2O
20% Hybridization Buffer For 40 mL of solution
20% Formamide 8 mL of Formamide
5× SSC 10 mL of 20× SSC
9 mM Citric Acid (pH 6.0) 360 µL of 1 M Citric Acid (pH 6.0)
0.1% Tween 20 400 µL of 10% Tween 20
50 µg/mL Heparin 200 µL of 10 mg/mL Heparin
1× Denhardt’s Solution 800 µL of 50× Denhardt’s Solution
10% Dextran Sulfate 10 mL of 50% Dextran Sulfate
Fill up to 40 mL with ultrapure H2O
20% Probe Wash Buffer For 40 mL of solution
20% Formamide 8 mL of Formamide
5× Sodium Chloride Sodium Citrate
(SSC)
10 mL of 20× SSC
9 mM Citric Acid (pH 6.0) 360 µL of 1 M Citric Acid (pH 6.0)
0.1% Tween 20 400 µL of 10% Tween 20
50 µg/mL Heparin 200 µL of 10 mg/mL Heparin
Fill up to 40 mL with ultrapure H2O
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Amplification Buffer For 40 mL of solution
5× Sodium Chloride Sodium Citrate
(SSC)
10 mL of 20× SSC
0.1% Tween 20 400 µL of 10% Tween 20
10% Dextran Sulfate 10 mL of 50% Dextran Sulfate
Fill up to 40 mL with ultrapure H2O
Phalloidin Staining Buffer For 200 µL of solution
1× Phalloidin 5 µL of stock Phalloidin
Fill up to 200 µL with PBST
Literature Hybridization Buffer
Probes hybridized at 35 ◦C.
30% Formamide
900 mM NaCl
20 mM Tris-HCl
0.1% Sodium Dodecyl Sulfate
Literature Wash Buffer
Probes washed at 37 ◦C.
64 mM NaCl
20 mM Tris-HCl
5 mM EDTA
0.1% Sodium Dodecyl Sulfate
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C.3.4 Reagents and Supplies
Alexa Fluor 488 Phalloidin (Thermo Fisher Cat. # A12379)
CytoPainter Phalloidin-iFluor 405 (Abcam Cat. # AB176752)
HCR Amplifiers and Buffers (Molecular Instruments)
Paraformaldehyde (PFA, 16% methanol free) (Alfa Aesar Cat. # 43368)
ProLong Gold Antifade Mountant (Thermo Fisher Cat. # P36930)
Wheaton Coplin Staining Jar (Sigma Aldrich Cat. # S6016)
10× Phosphate-buffered saline (PBS) (Ambion Cat. # AM9625)
20× Sodium chloride sodium citrate (SSC) (Invitrogen Cat. # 15557-044)
25 mm x 25 mm No. 1 coverslip (VWR Cat. # 48393-)
25 mm x 75 mm glass slide (VWR Cat. # 48393-048)
50% Tween 20 (Invitrogen Cat. # 00-3005)
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